cyclosporine has been researched along with Arthritis, Rheumatoid in 341 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 188 (55.13) | 18.2507 |
| 2000's | 109 (31.96) | 29.6817 |
| 2010's | 38 (11.14) | 24.3611 |
| 2020's | 6 (1.76) | 2.80 |
| Authors | Studies |
|---|---|
| Ahirrao, P; Bakhle, D; Bhankhede, T; Bhonde, M; Bokan, S; Budhe, S; Dadke, D; Daler, J; Deshmukh, G; George, SK; Gholve, M; Gundu, J; Gupta, R; Ingawale, S; Irlapatti, NR; Jachak, S; Kalia, A; Kamalakannan, P; Kamboj, RK; Kanoje, V; Karche, V; Khedkar, NR; Kizhakinagath, PA; Kuldharan, S; Kumar, H; Kumar, S; Mallurwar, S; Mehta, M; Modi, D; Naik, K; Narasimham, L; Nemade, HN; Nemmani, KVS; Nigade, P; Padiya, KJ; Palle, VP; Pandey, D; Pareek, H; Patil, A; Patil, V; Pawar, S; Phukan, S; Shah, C; Shaikh, Z; Shankar, R; Sharma, N; Sharma, S; Shinde, V; Sindkhedkar, M; Singh, M; Sinha, N; Tamane, K; Venugopal, S; Vishwase, G; Wagh, A; Yeshodharan, R | 1 |
| Abeygunawardena, S; Jayalath, T; Karunathilake, P; Ralapanawa, U; Rathnayaka, M; Weerasinghe, S | 1 |
| Amiri, N; Baldwin, C; De Vera, MA; Rebić, N; Sayre, EC; Zusman, EZ | 1 |
| Ellingsen, T; Hornung, N; Odderskov, C; Stengaard-Pedersen, K | 1 |
| Adzatia, KE; Anavi, KR; Nel, C; Nel, JS; Savage-Reid, MJ | 1 |
| Ahmadzadeh, A; Amini, E; Daneshi, A; Daraei, M; Jalessi, M; Peyvandi, AA; Ranjbar, LA | 1 |
| Deng, W; Miao, C; Zhang, X | 1 |
| Guo, C; Wu, R; Zheng, N | 1 |
| Brahe, CH; Dehlendorff, C; Ellingsen, T; Hansen, I; Hetland, ML; Hørslev-Petersen, K; Jacobsen, S; Johansen, JS; Junker, P; Jurik, AG; Lindegaard, H; Lottenburger, T; Stengaard-Pedersen, K; Ørnbjerg, LM; Østergaard, M | 1 |
| Fernandez, AP; Hu, JZ; Husni, ME; Mazloom, SE; Warren, CB; Ya, J; Yan, D | 1 |
| Busmanis, I; Lee, HY; Lian, BS | 1 |
| Almond, LM; Gardner, I; Jamei, M; Joshi, A; Kenny, JR; Machavaram, KK; Rostami-Hodjegan, A; Tay, S; Wong, S | 1 |
| Abrahamsen, B; Andersen, LS; Ellingsen, T; Hansen, I; Hansen, MS; Hetland, ML; Hyldstrup, L; Hørslev-Petersen, K; Jensen, TW; Junker, P; Jurik, AG; Langdahl, B; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Pedersen, JK; Pødenphant, J; Skjødt, H; Stengaard-Petersen, K; Svendsen, AJ; Tarp, U; Vestergaard, A; Zerahn, B; Østergaard, M | 1 |
| Andersen, LS; Christensen, AF; Ellingsen, T; Hansen, I; Hetland, ML; Hørslev-Petersen, K; Jacobsen, S; Junker, P; Jurik, AG; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Møller, BK; Pedersen, JK; Skjødt, H; Stengaard-Pedersen, K; Svendsen, A; Tarp, U; Thorsen, J; Vestergaard, A; Østergaard, M | 1 |
| Bader, RA; Forstner, MB; Silvers, AL; Wilson, DR; Zhang, N | 1 |
| Deleuran, B; Greisen, SR; Hetland, ML; Hvid, M; Hørslev-Petersen, K; Rasmussen, TK; Stengaard-Pedersen, K | 1 |
| Cope, AP; Dahanayake, C; Lewis, CM; Ma, MH; Scott, DL; Scott, IC; Seegobin, SD | 1 |
| D'Amelio, R; Laganà, B; Picchianti-Diamanti, A; Rosado, MM; Scarsella, M | 1 |
| Hernández Alava, M; Ibrahim, F; Scott, DL; Scott, IC; Wailoo, A | 1 |
| Cope, AP; Dahanayake, C; Ma, MH; Scott, DL; Scott, IC | 1 |
| Allaart, CF; de Vries-Bouwstra, JK; Han, KH; Huizinga, TW; Kerstens, PJ; Lems, WF; Markusse, IM; Schouffoer, AA; van der Lubbe, PA | 1 |
| Chang, YT; Chen, CC; Chen, DY; Chen, YJ; Ho, HJ; Kuo, KN; Liu, HN; Shen, JL; Wu, CY | 1 |
| Anelli, MG; Cacciapaglia, F; Covelli, M; Iannone, F; Lapadula, G; Rinaldi, A; Scioscia, C; Serafino, L | 1 |
| Bierma-Zeinstra, SM; Boers, M; Cardoso, JR; de Bie, R; de Vet, HC; Lambeck, J; Verhagen, AP | 1 |
| Chen, CJ; Cheng, TT; Lin, JC; Lin, KM | 1 |
| Bachta, A; Bogusławska-Walecka, R; Duda, K; Juszkiewicz, A; Kisiel, B; Kruszewski, R; Kłos, K; Płoski, R; Raczkiewicz, A; Staniszewska-Varga, J; Tłustochowicz, M; Tłustochowicz, W | 1 |
| Srinivas, NR | 1 |
| Briggs, Z; Gardner, DH; Hou, TZ; Jeffery, LE; Raza, K; Sansom, DM; Soskic, B | 1 |
| Herrera, MA; Kass, PH; Rhoades, AC; Sykes, JE; Vernau, W | 1 |
| Fujimi, A; Hashimoto, A; Hayasaka, N; Iwasaki, S; Kanisawa, Y; Kato, J; Minami, S; Nakajima, C; Okuda, T; Suzuki, A; Yamada, S; Yamauchi, N | 1 |
| Andersen, LS; Ejbjerg, BJ; Ellingsen, T; Eshed, I; Glinatsi, D; Hansen, IT; Hanson, LG; Hetland, ML; Hørslev-Petersen, K; Junker, P; Jurik, AG; Krogh, NS; Lindegaard, H; Lottenburger, T; Møller-Bisgaard, S; Pedersen, JK; Pødenphant, J; Skjødt, H; Stengaard-Pedersen, K; Svendsen, AJ; Tarp, U; Thomsen, H; Torfing, T; Vestergaard, A; Østergaard, M | 1 |
| Bollea-Garlatti, ML; Galimberti, RL; Torre, AC; Vacas, AS; Warley, F | 1 |
| Andrianakos, A; Charalambopoulos, D; Karanikolas, G; Karras, D; Kaskani, E; Rapti, A; Sfikakis, PP; Vaiopoulos, G | 1 |
| Alamanos, Y; Drosos, AA; Voulgari, PV | 1 |
| D'Angelo, S; Olivieri, I; Palazzi, C | 1 |
| Frank, J; Kucharekova, M; Poblete-Gutiérrez, P; Winnepenninckx, V | 1 |
| Ideguchi, H; Ishigatsubo, Y; Kaneko, T; Ohno, S; Takase, K; Tsukahara, T | 1 |
| Pandit, RT | 1 |
| Akpek, EK; Gupta, A; Sadeghi, PB | 1 |
| Gergely, P; Poór, G | 1 |
| Mimori, T; Yukawa, N | 1 |
| Bellisai, F; Ferri, C; Galeazzi, M; Giannitti, C | 1 |
| Allaart, CF; Dijkmans, BA; Huizinga, TW; Kerstens, PJ; Klarenbeek, NB | 1 |
| Bejarano, V; Brown, AK; Buch, MH; Conaghan, PG; Emery, P; Proudman, SM | 1 |
| Harada, K; Kawamura, T; Nakagomi, D; Shibagaki, N; Shimada, S; Yagasaki, A | 1 |
| Förger, F; Østensen, M | 1 |
| Ehrenstein, B; Fleck, M; Hartung, W; Pongratz, G; Schölmerich, J | 1 |
| Andersen, LS; Ejbjerg, BJ; Ellingsen, T; Hansen, I; Hetland, ML; Hørslev-Petersen, K; Jacobsen, S; Junker, P; Jurik, AG; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Pedersen, JK; Pødenphant, J; Stengaard-Pedersen, K; Svendsen, A; Tarp, U; Vestergaard, A; Østergaard, M | 1 |
| Bakker, MF; Bijlsma, JW; Jacobs, JW; Lafeber, FP; Linn-Rasker, SP; van der Veen, MJ; van der Werf, JH; Welsing, PM | 1 |
| Tsuda, H; Tsuji, T; Yamasaki, H | 1 |
| Beaulieu, A; Rashford, M; Schiff, M; Scott, DL | 1 |
| Lamy, T; Loughran, TP | 1 |
| Brzosko, I; Fliciński, J; Ostanek, L; Prajs, K; Przepiera-Bedzak, H | 1 |
| Kiss, CG; Kiss, E; Poór, G | 1 |
| Chu, DH; Rosenbach, M; Van Voorhees, AS | 1 |
| Hetland, ML | 1 |
| Huang, HB; Lai, NS; Lu, MC; Tung, CH; Yin, WY; Yu, CL; Yu, HC | 1 |
| Ichinose, A; Ieko, M; Inoue, M; Kasahara, Y; Kurita, T; Majima, T; Matsuoka, M; Onodera, T; Souri, M; Takahashi, D | 1 |
| Damato, R; Di Poi, E; Favret, G; Ferraccioli, GF; Gremese, E; Tomietto, P | 1 |
| Feldman, SR; Housman, TS; Mellen, BG; Rodewald, EJ | 1 |
| Alamanos, Y; Bougias, DV; Drosos, AA; Georgiadis, AN; Temekonidis, TI; Voulgari, PV | 1 |
| Heiligenhaus, A; Heinz, C; Hoeft, S; Hudde, T; Neudorf, U; Steuhl, KP | 1 |
| Assaloni, R; De Marchi, G; Di Poi, E; Fabris, M; Ferraccioli, GF; Gremese, E | 1 |
| Bertouch, JV; Lim, IG | 1 |
| Aletaha, D; Smolen, JS | 1 |
| Tanaka, Y; Tsujimura, S | 1 |
| Gross, WL; Schnabel, A | 1 |
| Afonso, A; Cardoso, J; Chaveiro, MA; Vieira, R | 1 |
| Bruijn, GA; Bruyn, GA; Dijkmans, BA; Gerards, AH; Goei Thé, HS; Laan, RF; Landewé, RB; Prins, AP | 1 |
| Baggott, JE; Choc, MG; Fox, RI; Morgan, SL; Robbins, BA; Smith, HT | 1 |
| Arreghini, M; Battafarano, N; Gallazzi, M; Marchesoni, A; Panni, B; Tosi, S | 1 |
| Førre, Ø; Haga, HJ; Johnsen, V; Kvien, TK; Mikkelsen, K; Nordvåg, BY; Rødevand, E | 1 |
| Araghi, P; Bianchi, G; Ciabattoni, M; Icardi, A; Lazzarini, P; Romano, U | 1 |
| Balabanova, RM | 1 |
| Belin, V; Tebib, J; Vignon, E | 1 |
| Bonanno, D; Fedele, R; Ferlazzo, B; Minciullo, P; Quattrocchi, P | 1 |
| Alfieri, G; Atzeni, F; Beyene, NB; Cazzola, M; Chérié-Lignière, EL; Corbelli, V; D'Ingianna, E; Fiorentini, F; Fiorini, T; Fumagalli, M; Locati, M; Mastaglio, C; Menozzi, G; Monti, G; Panni, B; Saccardo, F; Sarzi-Puttini, P; Scarpellini, M; Severi, C | 1 |
| Saxne, T; Wollheim, FA | 1 |
| Conaghan, PG; Emery, P | 1 |
| Grau, JM; López, B; Rovira, M; Sanjurjo, E | 1 |
| Darmawan, J; Nuralim, H; Rasker, JJ | 1 |
| Burmester, GR; Müller-Ladner, U; Rüther, W | 1 |
| Ahmad, SL; Farooqui, AN; Mansuri, FA | 1 |
| Constantin, T; Dankó, K; Ponyi, A | 1 |
| Emery, P; Suarez-Almazor, M | 1 |
| Burmester, GR; Buttgereit, F; Dziurla, R; Gaber, T; Tripmacher, R | 1 |
| Banks, M; Kitas, GD; Raza, K | 1 |
| Fath, R | 1 |
| Burmester, GR | 1 |
| Boumpas, DT; Choulaki, C; Kouroumali, H; Koutala, H; Kritikos, H; Mamoulaki, M; Raptopoulou, A; Siakka, P; Sidiropoulos, PI | 1 |
| De Santis, M; Ferraccioli, GF; Tomietto, P | 1 |
| Kaminuma, O; Miyatake, S | 1 |
| Gordon, KB; Ruderman, EM | 1 |
| Andrianakos, A; Antoniades, C; Charalambopoulos, D; Karanikolas, G; Katsilambros, N | 1 |
| Andersen, LS; de Carvalho, A; Ellingsen, T; Hansen, G; Hansen, I; Hetland, ML; Hørslev-Petersen, K; Junker, P; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Pedersen, JK; Pødenphant, J; Skjødt, H; Stengaard-Pedersen, K; Svendsen, A; Tarp, U; Østergaard, M | 1 |
| Caggiari, L; De Re, V; De Vita, S; Fabris, M; Ferraccioli, G; Franzolini, N; Gasparotto, D; Marzotto, A; Quartuccio, L; Scott, CA | 1 |
| Andonopoulos, AP; Antonopoulos, I; Daoussis, D; Liossis, SN | 1 |
| Cho, CS; Kim, WU; Koh, HS; Lee, MS; Miyazawa, K; Park, BH; Park, GS; Park, SH; Ryu, SH; Yoo, SA | 1 |
| Bellisai, F; Donvito, A; Galeazzi, M; Giannitti, C | 1 |
| Cho, ML; Cho, YG; Ju, JH; Kim, HS; Kim, HY; Kim, KW; Lee, SH; Lee, SY; Min, SY; Moon, YM; Park, KS; Park, SH; Yoon, CH | 1 |
| Ikeda, K; Shimizu, Y; Sugahara, S; Yamamoto, S | 1 |
| Saito, E; Suwa, A; Suzuki, Y; Wakabayashi, T | 2 |
| Kawai, S; Kitahara, K | 1 |
| Chuang, E; Molitch, ME | 1 |
| Tłustochowicz, W | 1 |
| Tłustochowicz, M | 1 |
| Chau, L; Choy, EH; Farewell, V; Hassell, A; Scott, DL; Smith, CM; Walker, D | 1 |
| Andersen, LS; Ellingsen, T; Hansen, GV; Hansen, I; Hetland, ML; Hørslev-Petersen, K; Junker, P; Jurik, AG; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Pedersen, JK; Skjødt, H; Stengaard-Pedersen, K; Svendsen, A; Tarp, U; Vestergaard, A; Østergaard, M | 1 |
| Wu, C; Yang, B; Zhang, C; Zhang, J | 1 |
| Renner, R; Sticherling, M | 1 |
| Hoch, S; Huppert, A; Schlesinger, N | 1 |
| Malleson, P | 1 |
| Steinberg, AD | 1 |
| Birnbaum, AH; Rosh, JR | 1 |
| Kamel, OW; van de Rijn, M | 1 |
| Storb, R; Thomas, ED | 1 |
| Bombardier, C; Buchbinder, R; Tugwell, P; Yeung, M | 1 |
| Lacki, JK; Mackiewicz, SH; Müller, W; Porawska, W; Sobieska, M | 1 |
| Choy, E; Kingsley, G | 1 |
| Figueroa, F; Gutiérrez, F; Jacobelli, S; Martínez, ME; Massardo, L; Rivero, S | 1 |
| Forslund, T; Fyhrquist, F; Hannonen, P; Reitamo, S | 1 |
| Bartoli, E; Ferraccioli, G; Guerra, P; Rizzi, V | 1 |
| De Witte, T; Dompeling, EC; Schattenberg, A; Swaak, AJ; Vreugdenhil, G | 1 |
| Benfield, P; Faulds, D; Goa, KL | 1 |
| Casoli, P; Tumiati, B | 1 |
| Amor, B; Capell, HA; Crilly, A; Dougados, M; Kolta, S; Madhok, R; Sturrock, RD | 1 |
| Bax, D; Gawkrodger, D; Nisar, M | 1 |
| Cash, JM; Wilder, RL | 1 |
| Breedveld, FC; Dijkmans, BA; Goei The, HS; Landewé, RB; Mattie, H; van den Borne, BE | 1 |
| Bartoli, E; Boiocchi, M; Carbone, A; Casatta, L; De Vita, S; Dolcetti, R; Ferraccioli, GF | 1 |
| Baker, P; Gluck, O; Kraag, G; McKendry, R; Pincus, T; Stein, M; Tesser, J; Tugwell, P; Wells, G; Yocum, D | 1 |
| Breedveld, FC | 1 |
| Breedveld, FC; Dijkmans, BA; Goei The, HS; Landewe, RB; Rietveld, JR; van Rijthoven, AW | 1 |
| Coari, G; Fiore, D; Iagnocco, A; Riccieri, V; Sili Scavalli, A; Spadaro, A; Taccari, E; Zoppini, A | 1 |
| Borel, JF; Kovarik, J; Kuntz, L; Ryffel, B | 1 |
| Nasonov, EL; Nasonova, VA; Shtutman, VZ | 1 |
| Arnaud, M; Bertin, P; Bourdeix, I; Combe, B; Courthéoux, F; Dougados, M; Flipo, RM; Job-Deslandre, C; L'Hirondel, JL; Reigneau, O | 1 |
| Bensen, W; Gent, M; Grace, E; Ludwin, D; Roberts, RM; Ross, H; Tugwell, P | 1 |
| Cook, RJ | 1 |
| Panayi, GS; Tugwell, P | 2 |
| Campo, C; Gómez Casares, MT; Jiménez, S; Malcorra, JJ; Mataix, R; Pérez, MC | 1 |
| Førre, O | 2 |
| Coblyn, JS; Germain, BF; Kremer, JM; Maier, AL; Wall, BA; Weinblatt, ME; Weisman, MH | 1 |
| Favre, H; Lemoine, R; Miescher, PA | 1 |
| Duffill, MB | 1 |
| Berry, H; du Vivier, AW; Higgins, EM; Hughes, JR; Smith, E | 1 |
| Bruno, M; Cosseddu, D; Linari, F; Manganaro, M; Pellerito, R; Ravarino, N; Torchio, B; Urbano, D | 1 |
| Sigidin, IaA; Usova, SB | 1 |
| Follath, F; Fontana, A; Leumann, E; Michel, BA; Miescher, PA; Schreier, M; Schroeder, M; Wenk, M | 1 |
| Longmire, AW; Minton, TA; Morrow, JD; Pincus, T; Roberts, LJ; Stein, CM | 1 |
| Cortet, B; Delcambre, B; Duquesnoy, B; Flipo, RM | 1 |
| Krüger, K; Schattenkirchner, M | 1 |
| Furst, DE | 2 |
| Berg, KJ; Førre, O; Hovig, T; Kvien, TK; Sund, S | 1 |
| Kubanek, B; Noé, G; Rich, IN; Schrezenmeier, H | 1 |
| Breedveld, FC; Dijkmans, BA; Goei Thè, HS; Landewé, RB; van Rijthoven, AW | 1 |
| Rovenský, J; Stancíková, M | 1 |
| Alexopoulou, I; Esdaile, JM; Ludwin, D; Tugwell, P | 1 |
| Bakker, NP; Groenestein, R; Hart, LA; Jonker, M; Van Besouw, N | 1 |
| Burmester, GR; Rubbert, A | 1 |
| Heck, LW; Koopman, WJ; Moreland, LW; Pratt, PW; Sullivan, W | 1 |
| Horton, S; Resman-Targoff, BH; Thompson, DF | 1 |
| Yocum, D | 1 |
| Bombardier, C | 1 |
| Graveley, R; Russell, RG; Skjodt, H | 1 |
| Tugwell, P; Wells, G | 1 |
| Dougados, M; Torley, H | 1 |
| Alexopoulou, I; Ludwin, D | 1 |
| Arellano, F; Krupp, P | 1 |
| Kurki, P | 1 |
| Speed, C | 1 |
| Falkenbach, A; Jörgens, K; Kaltwasser, JP; Martinovic, A; Scheuermann, EH; Seiffert, UB; Unkelbach, U; Wigand, R | 1 |
| Stein, CM | 1 |
| Redford, TW; Small, RE | 1 |
| Kinirons, MT; Pincus, T; Stein, CM; Wilkinson, GR; Wood, AJ | 1 |
| Chang, DM; Chiao, SF | 1 |
| Chalmers, A; Klinkhoff, AV; Ostrow, DN; Puttick, MP | 1 |
| Trnavský, K | 1 |
| Torley, H; Yocum, DE | 1 |
| Della Casa-Alberighi, O; Fantini, F; Ferraccioli, G; Magaro, M; Marcolongo, R; Marubini, E; Oriente, P; Pasero, G; Pipitone, V; Portioli, I; Priolo, F; Tirri, G; Trotta, F | 1 |
| Emery, P; Richardson, C | 1 |
| Yocum, DE | 5 |
| Dijkmans, BA | 1 |
| Tugwell, P | 3 |
| Anis, AH; Stewart, DG; Tugwell, PX; Wells, GA | 1 |
| Carotti, M; Cervini, C; Salaffi, F | 1 |
| Lacki, JK; Mackiewicz, S; Mackiewicz, U; Samborski, W | 1 |
| Emery, P; van de Putte, LB | 1 |
| Cutolo, M; Della Casa-Alberighi, O; Fantini, F; Ferraccioli, GF; Marubini, E; Mathieu, A; Pasero, G; Priolo, F | 1 |
| Dijkmans, BA; Førre, O; Harrison, WB; Krayenbühl, JC; Miescher, PA; Mihatsch, MJ; Rodríguez, F; Tugwell, P | 1 |
| Breedveld, FC; Dijkmans, BA; Landewe, RB; Miltenburg, AM; van den Borne, BE; Verweij, CL | 1 |
| Pei, Y | 1 |
| Breedveld, FC; Bruijn, JA; Dijkmans, BA; Landewé, RB; Mihatsch, MJ; van der Woude, FJ | 1 |
| De Backer, M; De Keyser, P; Lesaffre, E; Malaise, MG; van Lierde, MA | 1 |
| Bentin, J | 1 |
| Baker, P; Tugwell, P | 1 |
| Chiba, S; Horigome, I; Hotta, O; Kitamura, H; Miyazawa, S; Sudou, K; Taguma, Y; Tokoi, T | 1 |
| Bartoli, E; Casatta, L; Ferraccioli, G | 1 |
| Flipo, RM; Reigneau, O | 1 |
| Akizuki, M; Fujii, T; Ikeda, Y; Kameda, H; Mimori, T; Yajima, T | 1 |
| Breedveld, FC; Dijkmans, BA; Landewé, RB; The, HS; van den Borne, BE | 1 |
| Bendix, G; Bjelle, A | 1 |
| Arakawa, M; Hasegawa, H; Nakano, M; Nishi, S; Saito, T; Ueno, M | 1 |
| Alten, R; Genth-Stolzenburg, S; Guerret, M; Kovarik, JM; Kurki, P; Markert, E; Mueller, E; Zeidler, H | 1 |
| Cecchin, E; De Marchi, S; Zanello, F | 1 |
| Francheteau, P; Gerbeau, C; Guerret, M; Kovarik, JM; Mueller, EA; Tarral, A | 1 |
| Homma, M | 1 |
| Alarcón, GS | 1 |
| Ataman, S; Ergin, S; Kutlay, S; Savaş, S; Yalçin, P | 1 |
| Accardo, S; Barone, A; Carruba, G; Castagnetta, L; Cutolo, M; Giusti, M; Granata, O; Sulli, A; Villaggio, B | 1 |
| Baker, P; Bensen, W; Gent, M; Grace, E; Ludwin, D; Roberts, R; Tugwell, P | 1 |
| Little, BB | 1 |
| Schiff, M | 1 |
| Dawson, JK; Roychowdhury, B; Tunn, EJ | 1 |
| Brooks, RH; Pincus, T; Stein, CM | 1 |
| Brooks, RH; Gluck, O; Kraag, G; McKendry, R; Pincus, T; Stein, CM; Tesser, J; Torley, H; Tugwell, P; Wells, G; Yocum, D | 1 |
| Scott, DG; Somerville, MF | 1 |
| Chaudhuri, K; Madhok, R; Torley, H | 1 |
| Baranov, AA; Korshunov, NI; Medvedev, AN; Nasonov, EL; Shilkina, BN | 1 |
| Aydintuğ, O; Beksaç, M; Ilhan, O; Karavelioğlu, D; Ustün, C | 1 |
| Battafarano, N; Fantini, F; Leoni, L; Marchesoni, A; Padula, A; Pasero, G; Ruiu, G; Taglione, E; Zeni, S | 1 |
| Amici, F; Danieli, G; Danieli, MG; Fratini, M; Giovagnoni, A; Rossetti, L | 1 |
| Kawada, K; Nagai, H; Takaoka, Y; Tanahashi, M | 1 |
| Menninger, H | 1 |
| Pincus, T | 1 |
| Aeschlimann, AG | 1 |
| Blankenstein, MA; Dijkmans, BA; Giltay, EJ; Gooren, LJ; Popp-Snijders, C; van den Borne, BE; van Schaardenburg, D | 1 |
| Bizan, P; Gröger, M; Kiener, H; Redlich, K; Schett, G; Smolen, J; Steiner, G; Tohidast-Akrad, M; Xu, Q | 1 |
| Cawley, MI; Emery, P; Flipo, RM; James, DW; Prowse, PJ; Schmidt, AG; Scott, DG; Situnayake, RD; Whatmough, I | 1 |
| O'Dell, JR | 1 |
| Cranney, A; Tugwell, P | 1 |
| Breedveld, FC; Bruyn, GA; Dijkmans, BA; Goei The, HS; Landewé, RB; Rietveld, JH; van den Borne, BE; Zwinderman, AH | 1 |
| Førre, O; Geidel, H; Hafström, I; Hannonen, P; Kaltwasser, JP; Kurki, P; Kvien, TK; Laasonen, L; Leirisalo-Repo, M; Manger, B; Markert, ER; Prestele, H; Wollheim, FA; Zeidler, HK | 1 |
| Blanco, R; García-Porrúa, C; González-Gay, MA; Ibáñez, D; Marenco, JL; Sánchez-Bursón, J; Vázquez-Caruncho, M | 1 |
| Sieper, J | 1 |
| Casatta, L; Damato, R; De Vita, S; Di Poi, E; Falleti, E; Ferraccioli, G; Salaffi, F | 1 |
| Bernelot Moens, HJ; Breedveld, FC; Dijkmans, BA; Goei The, HS; Hazes, JM; Houkes, I; Kluin, PM; Landewé, RB; Schild, F; van den Borne, BE; van der Heyden, PC; Vandenbroucke, JP; Zwinderman, AH | 1 |
| O'Neill, EA | 1 |
| Williams, RO | 1 |
| Favre, H; Lemoine, R; Miescher, PA; Tamagnini, P | 1 |
| Dimitrijevic, M; Glisic, B; Mitrovic, D; Pavlica, L; Popovic, M | 1 |
| Dimitrijevic, M; Glisic, B; Obradovic, S; Pejnovic, N; Popovic, M; Popovic, R; Stefanovic, D | 1 |
| Callen, JP; John, GR; Wilson, DM | 1 |
| Anderson, IF; Bjørneboe, O; Chalmers, A; Dovland, H; Gilboe, IM; Hannonen, P; Helve, T; Keystone, EC; Kovarik, JM; Kraag, GR; Leirisalo-Repo, M; Mueller, E; Nissilä, M; Richard, F; Schmidt, AG; Whatmough, I | 1 |
| Boers, M; Cranney, A; Pham, B; Tugwell, P; Verhoeven, AC; Wells, G | 1 |
| Constantopoulos, A | 1 |
| Breedveld, FC; Dijkmans, BA; Goei The, HS; Landewé, RB; van den Borne, BE | 1 |
| Cush, JJ; Tugwell, P; Weinblatt, M; Yocum, D | 1 |
| Abdeddaïm, M; Bertin, P; Bonnet, C; Carpentier, N; Druet-Cabanac, M; Trèves, R; Vergne, P | 1 |
| Klassen, LW; Moore, GF; O'Dell, JR | 1 |
| Kotyla, PJ; Kucharz, EJ; Sliwińska-Kotyla, B | 1 |
| Accardo, S; Cutolo, M; Pizzorni, C; Scotto-Busato, R; Sulli, A | 1 |
| Schattner, A | 1 |
| Hurst, NP | 1 |
| Bálint, G; Hodinka, L; Molnár, E; Rojkovich, B; Szegedi, G; Szilágyi, M; Szocsik, K; Tamási, L; Varjú, T | 1 |
| Altman, RD; Kopp, EJ; Schiff, M | 1 |
| Johns, KR; Littlejohn, GO | 1 |
| Padovan, M; Trotta, F | 1 |
| Weinblatt, ME | 1 |
| Baraldo, M; Ferraccioli, G; Furlanut, M; Gremese, E; Pea, F | 1 |
| Chwalinska-Sadowska, H; Klimczak, E; Koc, A; Ksiezopolska-Pietrzak, K; Luszczykiewicz, G; Maslinski, W; Ziolkowska, M | 1 |
| Allerberger, F; Gruber, J; Krugmann, J; Müller, T; Offner, FA; Sailer-Höck, M | 1 |
| Cho, CS; Cho, ML; Hong, YS; Joo, YS; Kim, HY; Kim, SI; Kim, WU; Lee, SH; Lee, SS; Min, JK; Park, SH; Yoo, WH | 1 |
| Chalom, EC; Kramer, N; Rosenstein, ED | 1 |
| Allard, S; Cohen, SB; Emery, P; Flipo, RM; Goobar, J; Jayawardena, S; Job-Deslandre, C; Jubb, RW; Krüger, K; Lopes Vaz, A; Manger, B; Mur, E; Nygaard, H; Rainer, F; Sack, MR; Schiff, MH; Schmidt, AG; Schnitzer, TJ; Trigg, LB; Weiner, SM; Whatmough, I; Yocum, DE | 1 |
| van Rijthoven, AW | 1 |
| Drosos, AA; Katsaraki, A; Voulgari, PV; Zikou, AK | 1 |
| Haguenauer, D; Shea, B; Suarez-Almazor, ME; Tugwell, P; Welch, VA; Wells, G | 1 |
| Martio, J | 1 |
| Ayer, LM; Issekutz, AC; Stadnyk, AW; Waterhouse, CC | 1 |
| Adebajo, A; Conaghan, PG; Emery, P; Gough, A; Green, MJ; Griffiths, B; Helliwell, P; Huston, G; Isaacs, J; Martin, M; McGonagle, D; Miles, S; Pease, C; Proudman, SM; Reece, RJ; Richardson, C; van der Heijde, DM; Veale, DJ; Wakefield, RJ | 1 |
| Benagiano, V; Cantatore, FP; Dammacco, F; Ria, R; Ribatti, D; Roncali, L; Vacca, A | 1 |
| García-Vicuña, R; González-Alvaro, I; Laffon, A; Ortiz, AM; Sánchez-Madrid, F; Sancho, D | 1 |
| Schiff, MH; Whelton, A | 1 |
| Hashimoto, H; Makino, H; Ogawa, D; Ueno, A; Wada, J; Yamamura, M; Yamasaki, Y | 1 |
| Dijkmans, BA; Nurmohamed, MT; Soesan, M; van Oers, MH; van Soesbergen, RM | 1 |
| Battagliotti, C; Díaz, EA; Garsd, A; Grosman, H; Gutfraind, E; Maccagno, A; Maldonado Cocco, J; Marcos, JC; Messina, DO; Onetti, CM; Otero, AB; Tate, G; Venarotti, HO | 1 |
| Akpek, EK; Gottsch, JD | 1 |
| Bauer, K; Dunky, A; Feyertag, J; Haberhauer, G; Kittl, EM; Skoumal, M | 1 |
| Cho, CS; Kim, HY; Kim, WU; Lee, SK; Lee, WK; Paek, SI; Park, SH; Seo, YI; Song, HH | 1 |
| Kremer, JM | 1 |
| Bordin, G; Brunelleschi, S; Colangelo, D; Lavagno, L; Viano, I | 1 |
| O'Dell, J | 1 |
| Anis, AH; Chalmers, A; Esdaile, JM; Fisher, JH; Guh, D; Marra, CA | 1 |
| Go, RS; Li, CY; Phyliky, RL; Tefferi, A | 1 |
| Garrood, T; Scott, DL | 1 |
| Doña Naranjo, MA; Riesco Díaz, M; Vargas Lebrón, C | 1 |
| Pisetsky, DS; St Clair, EW | 1 |
| Braun, J; Buss, B; Faerber, L; Machein, U; Rudwaleit, M; Sieper, J; Spiller, I | 1 |
| Cho, CS; Cho, ML; Kim, HY; Kim, WU; Lee, SH; Min, DJ; Min, JK; Min, SY; Park, SH | 1 |
| Dababneh, A; García-Porrúa, C; González-Gay, MA; Hajeer, AH; Mattey, DL; Ollier, WE; Thomson, W | 1 |
| Di Poi, E; Fabris, M; Ferraccioli, G; Mecchia, F | 1 |
| Flores, RH; Hochberg, MC; Tracy, JK | 1 |
| Baeten, D; De Backer, M; De Keyser, F; Geusens, P; Malaise, M; Raus, J; Stinissen, P; Van den Bosch, F; VanderBorght, A; Veys, EM | 1 |
| Kawaguchi, H; Maeda, S; Mori, T; Morishita, M; Naniwa, T; Ninomiya, S; Sugiura, Y; Tomita, H; Ueda, R; Yoshinouchi, T | 1 |
| Drosos, AA | 1 |
| Arreghini, M; Battafarano, N; Cagnoli, M; Cerase, A; Marchesoni, A; Pellerito, R; Priolo, F; Prudente, P; Tosi, S | 1 |
| Chaudhuri, K; Dubey, S; Zaphiropoulos, G | 1 |
| Chang, HK; Park, W; Ryu, DS | 1 |
| Kehlen, A; Langner, J; Riemann, D; Thiele, K | 1 |
| Førre, O; Hafström, I; Hannonen, P; Kaltwasser, JP; Kurki, P; Kvien, TK; Laasonen, L; Leirisalo-Repo, M; Manger, B; Prestele, H; Wollheim, FA; Zeidler, HK | 1 |
| Dawson, T; Findeisen, JM; Ryan, PF; Scheinkestel, CD | 1 |
| Boers, M; Cats, A; Dijkmans, BA; Goei Thè, HS; van Rijthoven, AW | 1 |
| Altman, RD; Perez, GO; Sfakianakis, GN | 1 |
| Black, MM; Cronin, E; Kavanagh, GM; Ross, JS; Smith, NP | 1 |
| Breedveld, FC; Daha, MR; Dijkmans, BA; Landewé, RB; Miltenburg, AM | 1 |
| Chalmers, A; Dubord, PJ; Kassen, BO; McCarthy, JM; Rangno, KK | 1 |
| Jaffe, IA | 1 |
| Husby, G; Kvien, TK | 1 |
| Bombardier, C; Buchbinder, R; Tugwell, P | 1 |
| Kurki, PT | 1 |
| Coxon, F; Del Pozo, E; Elford, P; Graveley, R; Mackenzie, A; Russell, RG; Skjodt, H | 1 |
| Appel, GB; Cohen, DJ | 1 |
| Dijkmans, BA; Jiwa, NM; Kluin, PM; Kluin-Nelemans, JC; van Rijthoven, AW; Zijlmans, JM | 1 |
| Fathman, CG; Myers, BD | 1 |
| Bensen, WG; Boers, M; Goldsmith, CH; Ludwin, D; Tugwell, P | 1 |
| Brooks, P | 1 |
| Epstein, RJ | 1 |
| Brown, H; Haimovici, R; Kervick, GN; Pflugfelder, SC; Tozman, E; Yee, R | 1 |
| Capell, HA; Madhok, R; Torley, HI | 1 |
| Ahern, MJ; Bayliss, C; Bradley, J; Harrison, W; Hollingsworth, P; Laing, B | 1 |
| Goronzy, JJ; Jendro, M; Weyand, CM | 1 |
| González, T; Hernández-Beriaín, JA; Rodríguez-Lozano, B | 1 |
95 review(s) available for cyclosporine and Arthritis, Rheumatoid
| Article | Year |
|---|---|
P-glycoprotein and drug resistance in systemic autoimmune diseases.
Topics: Adrenal Cortex Hormones; Arthritis, Psoriatic; Arthritis, Rheumatoid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Drug Resistance; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Tacrolimus | 2014 |
Balneotherapy (or spa therapy) for rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Balneology; Cyclosporine; Humans; Hydrotherapy; Mud Therapy; Osteoarthritis; Pain Management; Publication Bias; Radon; Randomized Controlled Trials as Topic | 2015 |
Hepatitis C virus-related arthritis.
Topics: Adrenal Cortex Hormones; Ankle; Antibodies, Viral; Arthralgia; Arthritis, Infectious; Arthritis, Rheumatoid; Chronic Disease; Cryoglobulinemia; Cyclooxygenase 2 Inhibitors; Cyclosporine; Hepacivirus; Hepatitis C; Humans; Hydroxychloroquine; Interferon-alpha; Methotrexate; Penicillamine; Purpura | 2008 |
[New ways in the management of rheumatoid arthritis in Hungary].
Topics: Abatacept; Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmunity; Azathioprine; Chloroquine; Cyclophosphamide; Cyclosporine; Diagnosis, Differential; Early Diagnosis; Etanercept; Humans; Hungary; Immunoconjugates; Immunoglobulin G; Immunologic Factors; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Prognosis; Receptors, Tumor Necrosis Factor; Rituximab; Sulfasalazine; Tumor Necrosis Factor-alpha | 2007 |
[Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Cysteine; Disease Progression; Drug Therapy, Combination; Gold Sodium Thiomalate; Humans; Isoxazoles; Leflunomide; Methotrexate; Penicillamine; Radiography; Randomized Controlled Trials as Topic; Sulfasalazine; Tacrolimus | 2009 |
Treatment strategies for a patient with rheumatoid arthritis and hepatitis C.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Prognosis; Receptors, Tumor Necrosis Factor; Treatment Outcome; Tumor Necrosis Factor-alpha | 2009 |
The BeSt story: on strategy trials in rheumatoid arthritis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Infliximab; Methotrexate; Prednisolone; Sulfasalazine | 2009 |
Management of RA medications in pregnant patients.
Topics: Abatacept; Acetaminophen; Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Contraindications; Cyclosporine; Female; Gestational Age; Glucocorticoids; Humans; Immunoconjugates; Isoxazoles; Leflunomide; Methotrexate; Pregnancy; Pregnancy Complications; Rituximab; Sulfasalazine; Young Adult | 2009 |
[Successful treatment with cyclosporine for myelodysplastic syndrome with erythroid hypoplasia following rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Cyclosporine; Erythroid Cells; Female; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes; Treatment Outcome | 2010 |
[Systemic autoimmune disorders and pregnancy].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Antiphospholipid Syndrome; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Remission Induction; Sjogren's Syndrome; Sulfasalazine; Teratogens; Tumor Necrosis Factor-alpha | 2011 |
The efficacy of 308nm laser treatment of psoriasis compared to historical controls.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Databases as Topic; Dermatologic Agents; Humans; Infliximab; Laser Therapy; Lasers; Phototherapy; Psoriasis; Severity of Illness Index; Time Factors; Treatment Outcome; Ultraviolet Therapy | 2001 |
[Clinical implication of cyclosporin for rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Resistance, Multiple; Humans; Immunosuppressive Agents; Methotrexate | 2002 |
[Combination therapy in rheumatoid arthritis].
Topics: Adjuvants, Immunologic; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine | 2003 |
[Kidney involvement in rheumatoid arthritis].
Topics: Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Autopsy; Biopsy; Cyclosporine; Glomerulonephritis; Humans; Kidney; Kidney Diseases; Methotrexate; Nephritis, Interstitial; Penicillamine; Time Factors | 2003 |
[Current concepts of pharmacotherapy in rheumatoid arthritis].
Topics: Adult; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Cyclophosphamide; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Feasibility Studies; Female; Glucocorticoids; Humans; Ibuprofen; Immunosuppressive Agents; Isoxazoles; Ketoprofen; Leflunomide; Male; Methotrexate; Prednisolone; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Sulfasalazine; Time Factors | 2003 |
[Diagnosis and therapy of rheumatoid arthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Arthroplasty; Cyclooxygenase Inhibitors; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Isoxazoles; Leflunomide; Methotrexate; Rheumatoid Factor; Sulfasalazine | 2004 |
Rheumatoid arthritis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Auranofin; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2003 |
Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do!
Topics: Arthritis, Rheumatoid; Cartilage, Articular; Cell Hypoxia; Cyclosporine; DNA-Binding Proteins; Genetic Therapy; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Immunosuppressive Agents; Lymphocyte Activation; Neovascularization, Pathologic; Nuclear Proteins; Oxygen; Synovial Membrane; Transcription Factors; Vascular Endothelial Growth Factor A | 2005 |
Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; CD28 Antigens; Colitis, Ulcerative; Cyclosporine; Cytokines; Dermatomyositis; Humans; Immune Tolerance; Immunosuppressive Agents; Inflammation; Lupus Erythematosus, Systemic; T-Lymphocytes | 2005 |
[Inhibitors of NFAT-calcineurin pathway].
Topics: Arthritis, Rheumatoid; Calcineurin; Cyclosporine; DNA-Binding Proteins; Immunophilins; NFATC Transcription Factors; Nuclear Proteins; Tacrolimus; Transcription Factors | 2005 |
The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Etanercept; Etretinate; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Keratolytic Agents; Methotrexate; Psoriasis; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 2006 |
[Inhibition of radiographic progression in rheumatoid arthritis by anti-rheumatic drugs (DMARDs)].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Disease Progression; Humans; Isoxazoles; Joints; Leflunomide; Methotrexate; Radiography; Remission Induction; Sulfasalazine | 2007 |
Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Safety; T-Lymphocytes; Tacrolimus; Tacrolimus Binding Proteins | 2007 |
[Rational therapeutic approach in rheumatoid arthritis].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Isoxazoles; Joint Prosthesis; Leflunomide; Methotrexate; Prostheses and Implants; Sulfasalazine | 2006 |
[Pathologic condition of osteoporosis in rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Bone Remodeling; Bone Resorption; Cell Differentiation; Cyclosporine; Disease Progression; Glucocorticoids; Humans; Menopause; Methotrexate; Osteoclasts; Osteoporosis; RANK Ligand; Tumor Necrosis Factor-alpha | 2007 |
How do second-line agents work?
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclophosphamide; Cyclosporine; Gold; Humans; Penicillamine; Sulfasalazine | 1995 |
Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.
Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Diabetes Mellitus, Type 1; Digestive System Diseases; Eye Diseases; Humans; Immune System Diseases; Nephrotic Syndrome; Nervous System Diseases; Skin Diseases | 1993 |
Refractory rheumatoid arthritis. Therapeutic options.
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Forecasting; Humans | 1995 |
[Prospects of the use of cyclosporin A in rheumatic diseases].
Topics: Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Behcet Syndrome; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Cyclosporine; Dermatomyositis; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Rheumatic Diseases; Sjogren's Syndrome | 1994 |
The use of cyclosporin A in rheumatoid arthritis: conclusions of an international review.
Topics: Administration, Oral; Arthritis, Rheumatoid; Contraindications; Cyclosporine; Drug Administration Schedule; Humans; Risk Factors | 1994 |
[Renal damage in rheumatoid arthritis].
Topics: Adult; Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclosporine; Female; Glomerulonephritis; Gold; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Methotrexate; Middle Aged; Penicillamine; Vasculitis | 1994 |
[Cyclosporin in autoimmune diseases].
Topics: Adult; Arthritis, Rheumatoid; Autoimmune Diseases; Child; Cyclosporine; Humans; Kidney Diseases; Lupus Erythematosus, Systemic; Nephrotic Syndrome | 1994 |
Optimizing combination chemotherapy for rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Drug Therapy, Combination; Humans; Methotrexate; Penicillamine | 1993 |
[New therapeutic possibilities. Future aspects].
Topics: Antibodies, Monoclonal; Arthritis, Rheumatoid; B-Lymphocytes; Cyclosporine; Cytokines; Humans; Immunization, Passive; Immunotherapy; Monitoring, Immunologic; Recombinant Proteins; T-Lymphocytes | 1993 |
New approaches to the therapy of autoimmune diseases: rheumatoid arthritis as a paradigm.
Topics: Antibodies, Monoclonal; Antigen-Presenting Cells; Antigens, CD; Arthritis, Rheumatoid; Autoimmune Diseases; B-Lymphocytes; Cell Adhesion Molecules; Cyclosporine; Cytokines; Forecasting; Humans; Lymphocyte Activation; Receptors, Antigen, T-Cell; T-Lymphocytes | 1993 |
Use of cyclosporine in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Humans; Randomized Controlled Trials as Topic | 1993 |
An international consensus report: the use of cyclosporin A in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cyclosporine; Europe; Humans; North America | 1993 |
The Use of Cyclosporin A in Rheumatoid Arthritis. Proceedings of an International Consensus Meeting. Buckinghamshire, United Kingdom, 19-20 July, 1992.
Topics: Arthritis, Rheumatoid; Cyclosporine; Humans | 1993 |
Immunological actions of cyclosporin A in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Cyclosporine; Humans | 1993 |
The optimal use of cyclosporin A in rheumatoid arthritis: efficacy and outcome measures including quality of life.
Topics: Arthritis, Rheumatoid; Cyclosporine; Humans; Prognosis; Quality of Life | 1993 |
The effects of cyclosporin A on bone and cartilage.
Topics: Arthritis, Rheumatoid; Bone and Bones; Cartilage; Cyclosporine; Humans | 1993 |
Cyclosporin A in rheumatoid arthritis: overview of efficacy.
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Evaluation; Humans | 1993 |
Efficacy of cyclosporin A in rheumatoid arthritis: worldwide experience.
Topics: Arthritis, Rheumatoid; Cyclosporine; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Multicenter Studies as Topic | 1993 |
Cyclosporin A nephropathy in patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cyclosporine; Humans; Kidney; Kidney Diseases | 1993 |
Cyclosporin A in rheumatoid arthritis--future perspectives.
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Therapy; Humans | 1993 |
Cyclosporine in the treatment of rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Interactions; Humans; Patient Selection; Risk Factors | 1995 |
Innovative treatment approaches for rheumatoid arthritis. Cyclosporin, leflunomide and nitrogen mustard.
Topics: Absorption; Alkylating Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Isoxazoles; Leflunomide; Mechlorethamine; Tissue Distribution | 1995 |
Cyclosporine in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Humans; Time Factors | 1995 |
Clinical use of cyclosporin in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Chemistry, Pharmaceutical; Cyclosporine; Drug Costs; Drug Therapy, Combination; Humans; Methotrexate | 1995 |
Combination therapy with cyclosporin in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Methotrexate | 1995 |
Safety aspects of cyclosporin in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Interactions; Guidelines as Topic; Humans; Kidney; Neoplasms | 1995 |
International consensus recommendations on cyclosporin use in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Chemistry, Pharmaceutical; Clinical Protocols; Cyclosporine; Humans; Kidney | 1995 |
A cost effectiveness analysis of cyclosporine in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cost-Benefit Analysis; Cyclosporine; Humans; Models, Economic; Ontario; Penicillamine; Randomized Controlled Trials as Topic | 1996 |
New perspectives on controlling progression of severe rheumatoid arthritis--a summary of the potential role of cyclosporin.
Topics: Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Drug Therapy, Combination; Humans | 1996 |
Combination therapy with cyclosporin in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Forecasting; Humans; Methotrexate; Rheumatology | 1996 |
Chloroquine combined with cyclosporine in rheumatoid arthritis: more than the addition of 2 drugs alone.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Cyclosporine; Drug Synergism; Drug Therapy, Combination; Humans | 1996 |
Combination therapy with cyclosporine in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Forecasting; Humans | 1996 |
Cyclosporine in rheumatoid arthritis: an overview.
Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Humans; Kidney | 1995 |
Mechanism of action of cyclosporin in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Biomechanical Phenomena; Bone and Bones; Connective Tissue; Cyclosporine; Humans; Immunosuppressive Agents; T-Lymphocytes | 1995 |
Guidelines for the use of cyclosporine in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cyclosporine; Humans; Practice Guidelines as Topic; Randomized Controlled Trials as Topic | 1995 |
Cyclosporine, FK-506, rapamycin, and other immunomodulators.
Topics: Arthritis, Psoriatic; Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Polyenes; Sirolimus; Tacrolimus | 1996 |
[Drug-induced renal disorders in patients with rheumatoid arthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Cysteine; Humans; Kidney Diseases; Methotrexate; ortho-Aminobenzoates | 1996 |
[ACR preliminary definition, of improvement in rheumatoid arthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Methotrexate; Quality of Life; Randomized Controlled Trials as Topic; Societies, Medical; Treatment Outcome; United States | 1996 |
Immunosuppressant therapy during gestation.
Topics: Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infant, Newborn; Lupus Erythematosus, Systemic; Organ Transplantation; Pregnancy; Pregnancy Complications; Steroids | 1997 |
Emerging treatments for rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies; Antirheumatic Agents; Arthritis, Rheumatoid; CD4 Antigens; Collagen; Cyclosporine; Humans; Hydroxyurea; Immunosuppressive Agents; Interleukin-1; Minocycline; Mycophenolic Acid; Tumor Necrosis Factor-alpha | 1997 |
The use of cyclosporin A microemulsion in rheumatoid arthritis: conclusions of an international review.
Topics: Arthritis, Rheumatoid; Contraindications; Cyclosporine; Drug Therapy, Combination; Emulsions; Europe; Guidelines as Topic; Humans; Immunosuppressive Agents; North America | 1997 |
Disease-modifying anti-rheumatic drugs. Cyclosporin.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Humans | 1997 |
[Basic therapeutic combination therapy in chronic polyarthritis: an overview].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Treatment Outcome | 1998 |
Combination therapy for rheumatoid arthritis with methotrexate and cyclosporine.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Treatment Outcome | 1998 |
Triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine in patients with rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine; Treatment Outcome | 1998 |
The use of Neoral in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biological Availability; Cyclosporine; Emulsions; Humans; Practice Guidelines as Topic | 1998 |
Combination therapy in mice: what can we learn that may be useful for understanding rheumatoid arthritis?
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibody Specificity; Antirheumatic Agents; Arthritis, Rheumatoid; CD4 Antigens; CD4-Positive T-Lymphocytes; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Humans; Interleukin-10; Interleukin-12; Mice; Pyrrolidinones; Rolipram; Time Factors; Tumor Necrosis Factor-alpha | 1998 |
[Cyclosporine: properties, mechanism of action and application in therapy of rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Cyclosporine; Humans | 1998 |
[Trends in the treatment of rheumatic diseases].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Bone Marrow Transplantation; Cyclooxygenase Inhibitors; Cyclosporine; Hand; Humans; Immunoglobulins, Intravenous; Knee Joint; Methotrexate; Osteoarthritis; Plasmapheresis; Radiography; Rheumatic Diseases; Tumor Necrosis Factor-alpha | 1999 |
The role of current strategies in the future treatment of rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Forecasting; Humans; Methotrexate | 1999 |
Cyclosporine for rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Humans | 2000 |
[Cytostatic drugs in the treatment of rheumatic and connective tissue diseases].
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Humans; Methotrexate; Podophyllotoxin | 1998 |
Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Humans; Kidney; Organogold Compounds; Penicillamine | 2000 |
Rational use of new and existing disease-modifying agents in rheumatoid arthritis.
Topics: Adjuvants, Immunologic; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Costs; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Risk Factors; Sulfasalazine | 2001 |
Combination therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Organogold Compounds | 2001 |
Progress in the treatment of rheumatoid arthritis.
Topics: Analgesics; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2001 |
"Stepping-up" from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Maximum Tolerated Dose; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Treatment Outcome | 2001 |
Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapy.
Topics: Animals; Arthritis, Rheumatoid; Cyclosporine; Cytokines; Gene Expression Regulation; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mitogen-Activated Protein Kinases; Mycophenolic Acid; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Sirolimus; Tacrolimus | 2002 |
Cyclosporine in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Clinical Trials as Topic; Cyclosporine; Humans; Immunity, Cellular; Kidney | 1992 |
New approaches to the management of rheumatoid arthritis.
Topics: Acquired Immunodeficiency Syndrome; Antibodies, Monoclonal; Arthritis, Rheumatoid; CD4 Antigens; Cyclosporine; Drug Therapy, Combination; Humans; Immunotherapy; Magnetic Resonance Imaging; Methotrexate; Photochemotherapy; Rheumatic Diseases; Rheumatology | 1992 |
Disease modification in rheumatoid arthritis with special reference to cyclosporin A.
Topics: Arthritis, Rheumatoid; Cyclosporine; Follow-Up Studies; Humans; Radiography; Time Factors | 1992 |
Efficacy of cyclosporin A in rheumatoid arthritis: long-term follow-up data and the effect on quality of life.
Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Follow-Up Studies; Humans; Quality of Life; Time Factors | 1992 |
Safety aspects of the long term cyclosporin A therapy.
Topics: Arthritis, Rheumatoid; Cyclosporine; Humans; Hypertension; Immune Tolerance; Kidney; Neoplasms; Prognosis; Time Factors | 1992 |
Cyclosporin A. Mode of action and effects on bone and joint tissues.
Topics: Arthritis, Rheumatoid; B-Lymphocytes; Bone and Bones; Cyclosporine; Cytokines; Humans; Joints; T-Lymphocytes | 1992 |
Cyclosporine in rheumatoid arthritis: documented efficacy and safety.
Topics: Arthritis, Rheumatoid; Azathioprine; Clinical Trials as Topic; Cyclosporine; Dose-Response Relationship, Drug; Humans; Kidney; Placebos | 1992 |
Cyclosporine in rheumatoid arthritis: beyond experimentation.
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Forecasting; Humans; Methotrexate; Synovial Membrane | 1992 |
Cyclosporine: nephrotoxic effects and guidelines for safe use in patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Cyclosporine; Humans; Kidney; Kidney Diseases | 1992 |
Cyclosporin in the treatment of rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cyclosporine; Humans; Treatment Outcome | 1992 |
Current issues of methotrexate and cyclosporine.
Topics: Arthritis, Rheumatoid; Cyclosporine; Humans; Methotrexate | 1992 |
[New approaches to the therapy of diffuse inflammatory diseases of the connective tissue].
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Connective Tissue Diseases; Cyclosporine; Drug Therapy, Combination; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymph; Methotrexate; Plasmapheresis; Synovitis | 1991 |
80 trial(s) available for cyclosporine and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Methotrexate pharmacokinetic is influenced by co-administration of cyclosporin in rheumatoid arthritis patients. Results from a randomized clinical trial.
Topics: Adult; Aged; Antirheumatic Agents; Area Under Curve; Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Drug Administration Schedule; Early Diagnosis; Erythrocytes; Female; Glomerular Filtration Rate; Humans; Male; Methotrexate; Middle Aged; Treatment Outcome | 2020 |
Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial.
Topics: Adult; Aged; Alendronate; Antirheumatic Agents; Arthritis, Rheumatoid; Betamethasone; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Resorption; Cyclosporine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intra-Articular; Lumbar Vertebrae; Male; Methotrexate; Middle Aged; Radiography; Treatment Outcome; Young Adult | 2014 |
Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression.
Topics: Adult; Aged; Antibodies, Anti-Idiotypic; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; CD4-Positive T-Lymphocytes; Chemokine CCL19; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Methotrexate; Middle Aged; Monocytes; Peptides, Cyclic; Radiography; Receptors, CCR7; Severity of Illness Index; Treatment Outcome; Up-Regulation | 2014 |
Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis.
Topics: Aged; Antibodies, Anti-Idiotypic; Arthritis, Rheumatoid; Betamethasone; Biomarkers; Case-Control Studies; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Interleukins; Longitudinal Studies; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Programmed Cell Death 1 Receptor; Radiography; Rheumatoid Factor; Severity of Illness Index | 2014 |
ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial.
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; Cyclosporine; Disease Progression; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Prednisolone; Quality of Life | 2014 |
Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis.
Topics: Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Remission Induction; Risk Factors; Sulfasalazine; Time Factors; Treatment Outcome | 2014 |
Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Certolizumab Pegol; Cholesterol; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Lipid Metabolism; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Sulfasalazine; Treatment Outcome; Triglycerides; Tumor Necrosis Factor-alpha | 2014 |
Comparison of the efficacy of prednisone and cyclosporine for treatment of dogs with primary immune-mediated polyarthritis.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Arthrocentesis; Carbazoles; Cyclosporine; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Male; Prednisone; Surveys and Questionnaires; Tramadol | 2016 |
Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis:
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Betamethasone; Bone Diseases; Cyclosporine; Double-Blind Method; Drug Administration Routes; Drug Delivery Systems; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Patient Acuity; Synovitis; Tendinopathy; Treatment Outcome | 2017 |
Adjunctive anakinra in patients with active rheumatoid arthritis despite methotrexate, or leflunomide, or cyclosporin-A monotherapy: a 48-week, comparative, prospective study.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2008 |
Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Prognosis; Treatment Outcome | 2009 |
Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Biomarkers; Bone Marrow Diseases; Cyclosporine; Disease Progression; Drug Therapy, Combination; Edema; Epidemiologic Methods; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Prognosis; Radiography; Remission Induction | 2010 |
Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study.
Topics: Administration, Oral; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Injections, Subcutaneous; Male; Methotrexate; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2010 |
Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; HLA-DR1 Antigen; Humans; Male; Methotrexate; Middle Aged; Pain; Sulfasalazine | 2002 |
Infliximab treatment in combination with cyclosporin A in patients with severe refractory rheumatoid arthritis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Chronic Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infliximab; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome | 2002 |
Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infliximab; Male; Methotrexate; Middle Aged; Remission Induction; Treatment Outcome | 2002 |
Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Radiography; Severity of Illness Index; Treatment Outcome | 2003 |
Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Radiography; Single-Blind Method; Treatment Outcome | 2003 |
An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pain Measurement; Severity of Illness Index; Treatment Outcome | 2005 |
Efficacy of cyclosporin-A in refractory rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Humans; Pain Measurement; Single-Blind Method | 2004 |
An open label, single dose study to evaluate the safety, efficacy, and effects on CD25 expression of ciclosporin in patients with active rheumatoid arthritis despite treatment with methotrexate and infliximab.
Topics: Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Infliximab; Lymphocyte Activation; Male; Methotrexate; Middle Aged; Pilot Projects; Receptors, Interleukin-2; Severity of Illness Index; Treatment Failure; Treatment Outcome; Tumor Necrosis Factor-alpha | 2006 |
Combination of cyclosporine and leflunomide versus single therapy in severe rheumatoid arthritis.
Topics: Adjuvants, Immunologic; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Isoxazoles; Joints; Leflunomide; Severity of Illness Index; Treatment Outcome | 2006 |
Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, par
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Betamethasone; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intra-Articular; Male; Methotrexate; Middle Aged | 2006 |
Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Foot Joints; Glucocorticoids; Hand Joints; Humans; Logistic Models; Male; Methotrexate; Middle Aged; Prednisolone; Quality of Life; Radiography; Treatment Outcome | 2008 |
Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Betamethasone; Combined Modality Therapy; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Injections, Intra-Articular; Male; Methotrexate; Middle Aged; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2008 |
Which outcome measures should be used in rheumatoid arthritis clinical trials? Clinical and quality-of-life measures' responsiveness to treatment in a randomized controlled trial.
Topics: Adolescent; Adult; Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Female; Humans; Individuality; Male; Middle Aged; Treatment Outcome | 1995 |
Acute phase response in rheumatoid arthritis patients treated with low doses of cyclosporin A.
Topics: Acute-Phase Proteins; Adult; Arthritis, Rheumatoid; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged | 1994 |
[Treatment with cyclosporine of refractory rheumatoid arthritis].
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Pressure; Creatinine; Cyclosporine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Time Factors | 1995 |
Cyclosporin A increases somatomedin C insulin-like growth factor I levels in chronic rheumatic diseases.
Topics: Arthritis, Psoriatic; Arthritis, Rheumatoid; Cyclosporine; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Osteocalcin | 1995 |
Relative bioavailability of a new oral form of cyclosporin A in patients with rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Biological Availability; Capsules; Cyclosporine; Emulsions; Female; Humans; Male; Middle Aged | 1995 |
Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group.
Topics: Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Severity of Illness Index; Treatment Outcome | 1995 |
Cyclosporine in common clinical practice: an estimation of the benefit/risk ratio in patients with rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Creatinine; Cyclosporine; Digestive System; Female; Follow-Up Studies; Humans; Hypertension; Kidney; Male; Middle Aged; Risk Factors | 1994 |
[The risk/benefit ratio of low-dose cyclosporin in the treatment of severe rheumatoid arthritis].
Topics: Adult; Aged; Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Male; Middle Aged; Odds Ratio; Prospective Studies | 1994 |
Combination therapy of cyclosporine with methotrexate and gold in rheumatoid arthritis (2 pilot studies).
Topics: Adult; Arthritis, Rheumatoid; Blood Pressure; Blood Urea Nitrogen; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Gold; Humans; Liver Function Tests; Male; Methotrexate; Middle Aged; Pilot Projects | 1994 |
Interim monitoring of bivariate responses using repeated confidence intervals.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Analysis of Variance; Arthritis, Rheumatoid; Asthma; Clinical Trials as Topic; Confidence Intervals; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Models, Statistical; Quality of Life; Therapeutic Equivalency | 1994 |
Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Norwegian Arthritis Study Group.
Topics: Administration, Oral; Adult; Aged; Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prednisolone; Radiography; Severity of Illness Index; Treatment Outcome | 1994 |
Lack of a renal-protective effect of misoprostol in rheumatoid arthritis patients receiving cyclosporin A. Results of a randomized, placebo-controlled trial.
Topics: Adult; Aged; Arthritis, Rheumatoid; Cyclosporine; Female; Gastrointestinal Diseases; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Misoprostol; Placebos; Prospective Studies | 1994 |
Use of cyclosporine in the treatment of autoimmune disorders.
Topics: Adult; Arthritis, Rheumatoid; Autoimmune Diseases; Cyclosporine; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Male; Methotrexate; Myelodysplastic Syndromes; Recurrence | 1994 |
[A comparative evaluation of the treatment results with cyclosporin A, methotrexate and azathioprine in rheumatoid arthritis patients (a preliminary report)].
Topics: Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Remission Induction; Time Factors | 1993 |
Cyclosporine-induced alterations in renal function are not associated with lipid peroxidation.
Topics: Arthritis, Rheumatoid; Creatinine; Cyclosporine; Double-Blind Method; Female; Humans; Kidney; Lipid Peroxidation; Male; Methotrexate; Middle Aged | 1994 |
Comparison of cyclosporin A and azathioprine in the treatment of rheumatoid arthritis--results of a double-blind multicentre study.
Topics: Arthritis, Rheumatoid; Azathioprine; Blood Pressure; Creatinine; Cyclosporine; Double-Blind Method; Female; Humans; Male; Middle Aged | 1994 |
A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Blood Pressure; Chloroquine; Creatinine; Cyclosporine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome | 1994 |
Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Pressure; Creatinine; Cyclosporine; Disease Progression; Female; Humans; Male; Middle Aged; Prospective Studies; Radiography; Severity of Illness Index; Time Factors; Treatment Outcome | 1996 |
Combination therapy of cyclosporine A with methotrexate or hydroxychloroquine in refractory rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Treatment Outcome | 1996 |
Do changes in clinical improvement in rheumatoid arthritis patients treated with immunosuppressive drugs reflect the changes in acute phase proteins?
Topics: Acute-Phase Proteins; Adult; alpha 1-Antichymotrypsin; alpha 1-Antitrypsin; Arthritis, Rheumatoid; C-Reactive Protein; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Humans; Immunoelectrophoresis; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Orosomucoid | 1995 |
Is the control of disease progression within our grasp? Review of the GRISAR study. (Gruppo Reumatologi Italiani Studio Artrite Reumatoide).
Topics: Adult; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Female; Humans; Male; Middle Aged; Prospective Studies; Radiography | 1996 |
Combination therapy with cyclosporin in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Forecasting; Humans; Methotrexate; Rheumatology | 1996 |
The use of Sandimmun (cyclosporin A) in severe refractory rheumatoid arthritis: the Belgian experience.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Creatinine; Cyclosporine; Female; Humans; Male; Middle Aged; Severity of Illness Index; Time Factors | 1995 |
Low dose cyclosporine in early rheumatoid arthritis: effective and safe after two years of therapy when compared with chloroquine.
Topics: Adolescent; Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Cyclosporine; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Radiography | 1996 |
Adding low-dose cyclosporin A to parenteral gold therapy in rheumatoid arthritis: a double-blind placebo-controlled study.
Topics: Adult; Aged; Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Drug Tolerance; Female; Gold; Gold Sodium Thiomalate; Humans; Infusions, Parenteral; Male; Middle Aged; Patient Compliance; Placebos | 1996 |
Diclofenac combined with cyclosporine in treatment refractory rheumatoid arthritis: longitudinal safety assessment and evidence of a pharmacokinetic/dynamic interaction.
Topics: Adult; Aged; Arthritis, Rheumatoid; Cyclosporine; Diclofenac; Drug Combinations; Drug Interactions; Female; Humans; Kidney; Longitudinal Studies; Male; Middle Aged | 1996 |
Cyclosporine and nonsteroidal antiinflammatory drugs: exploring potential drug interactions and their implications for the treatment of rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Area Under Curve; Arthritis, Rheumatoid; Cross-Over Studies; Cyclosporine; Drug Combinations; Drug Interactions; Humans; Indomethacin; Metabolic Clearance Rate; Piroxicam | 1997 |
Interaction between cyclosporin A and nonsteroidal antiinflammatory drugs.
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Combined Modality Therapy; Creatinine; Cross-Over Studies; Cyclosporine; Drug Interactions; Female; Glomerular Filtration Rate; Humans; Indomethacin; Ketoprofen; Male; Middle Aged; Treatment Outcome | 1997 |
Effect of combination therapy with cyclosporine and methotrexate on liver function test results in rheumatoid arthritis.
Topics: Alkaline Phosphatase; Antirheumatic Agents; Arthritis, Rheumatoid; Bilirubin; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Therapy, Combination; Humans; Liver; Liver Diseases; Liver Function Tests; Methotrexate | 1997 |
Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine Combination Study Group.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Time Factors; Treatment Outcome | 1997 |
Neoral--new cyclosporin for old?
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Behcet Syndrome; Biological Availability; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy; Emulsions; Humans; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone; Rheumatic Diseases; Severity of Illness Index; Surveys and Questionnaires | 1997 |
Pharmacokinetic effects of conversion to a new formulation of cyclosporin A in rheumatoid arthritis patients.
Topics: Adolescent; Adult; Arthritis, Rheumatoid; Biological Availability; Blood Pressure; Chemistry, Pharmaceutical; Creatinine; Cross-Over Studies; Cyclosporine; Data Interpretation, Statistical; Diastole; Dose-Response Relationship, Drug; Female; Gastrointestinal Diseases; Gingival Hyperplasia; Headache; Hemoglobins; Humans; Immunosuppressive Agents; Joints; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Systole; Time Factors; Tremor; Uric Acid | 1998 |
Safety and tolerability of conversion from stable Sandimmun maintenance treatment to Sandimmun Neoral in patients with rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Chemistry, Pharmaceutical; Cyclosporine; Female; Humans; Male; Middle Aged; Treatment Outcome | 1998 |
Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Cyclosporine; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Treatment Outcome | 1998 |
Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Female; Gold Sodium Thiomalate; Humans; Injections; Male; Middle Aged; Severity of Illness Index; Time Factors | 1998 |
Long-term followup of patients receiving combined therapy with cyclosporine and methotrexate.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Severity of Illness Index; Treatment Outcome | 1998 |
Circulating levels of interleukin 10 and other cytokines in rheumatoid arthritis treated with cyclosporin A or combination therapy.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydroxychloroquine; Immunoglobulins; Interleukin-10; Interleukins; Male; Middle Aged | 1998 |
Comparative study of the clinical efficacy of four DMARDs (leflunomide, methotrexate, cyclosporine, and levamisole) in patients with rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Female; Humans; Isoxazoles; Leflunomide; Levamisole; Male; Methotrexate; Middle Aged | 1998 |
Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: a double blind comparison to screen for differences in safety, efficacy, and pharmacokinetics.
Topics: Antirheumatic Agents; Area Under Curve; Arthritis, Rheumatoid; Biological Availability; Blood Pressure; Creatinine; Cyclosporine; Double-Blind Method; Drug Compounding; Emulsions; Female; Humans; Male; Middle Aged; Safety; Treatment Outcome | 1999 |
Androgenizing effects of cyclosporin A in rheumatoid arthritis.
Topics: Adult; Androgens; Androstane-3,17-diol; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Male; Middle Aged; Sex Characteristics; Testosterone | 1999 |
Cyclosporin and sulfasalazine combination in the treatment of early rheumatoid arthritis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Radiography; Sulfasalazine; Time Factors | 1999 |
Cyclosporine A in rheumatoid arthritis: randomized, placebo controlled dose finding study.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Female; Humans; Male; Middle Aged; Treatment Outcome | 1999 |
The safety and efficacy of cyclosporine (Neoral) in rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Treatment Outcome | 1999 |
Divergent effect of cyclosporine on Th1/Th2 type cytokines in patients with severe, refractory rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Cyclosporine; Cytokines; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Th1 Cells; Th2 Cells; Treatment Outcome | 2000 |
Microemulsion formulation of cyclosporin (Sandimmun Neoral) vs Sandimmun: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis. On behalf of the OLR 302 Study Group.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Blood Pressure; Chemistry, Pharmaceutical; Creatinine; Cyclosporine; Double-Blind Method; Emulsions; Humans; Joints; Middle Aged; Patient Satisfaction; Prospective Studies; Safety; Severity of Illness Index; Treatment Outcome | 2000 |
Influence of cyclosporin A on radiological progression in early rheumatoid arthritis patients: a 42-month prospective study.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Female; Hand; Humans; Hypertension; Male; Methotrexate; Nausea; Prospective Studies; Radiography; Time Factors; Wrist | 2000 |
Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone.
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Cyclosporine; Drug Therapy, Combination; Humans; Injections, Intra-Articular; Methotrexate; Patient Dropouts; Prognosis; Regression Analysis; Sulfasalazine; Therapeutic Equivalency; Treatment Outcome | 2000 |
Treatment with cyclosporin switching to hydroxychloroquine in patients with rheumatoid arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Hydroxychloroquine; Hypertension; Hypertrichosis; Linear Models; Male; Methotrexate; Middle Aged; Pilot Projects; Treatment Outcome | 2001 |
The effectiveness and toxicity of cyclosporin A in rheumatoid arthritis: longitudinal analysis of a population-based registry.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Pressure; Creatinine; Cyclosporine; Female; Humans; Male; Middle Aged; Treatment Outcome | 2001 |
Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis: effects of treatment with cyclosporin A (Neoral).
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Complementarity Determining Regions; Cyclosporine; Double-Blind Method; Female; Gene Expression; Gene Expression Profiling; Humans; Male; Middle Aged; Receptors, Antigen, T-Cell, alpha-beta; RNA, Messenger; Synovial Membrane | 2002 |
Step-down approach using either cyclosporin A or methotrexate as maintenance therapy in early rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Joints; Male; Methotrexate; Middle Aged | 2002 |
Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension.
Topics: Activities of Daily Living; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Creatinine; Cyclosporine; Disabled Persons; Female; Gold Sodium Thiomalate; Humans; Hypertension; Injections; Kidney Diseases; Long-Term Care; Male; Middle Aged; Treatment Outcome | 2002 |
Cyclosporine nephrotoxicity in rheumatoid arthritis: no effect of short term misoprostol treatment.
Topics: Adult; Arthritis, Rheumatoid; Cyclosporine; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Misoprostol; Time Factors | 1992 |
A study of the longterm efficacy and toxicity of cyclosporine A in rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Blood Sedimentation; Creatine; Cyclosporine; Humans; Kidney; Liver; Middle Aged; Pain Measurement; Time Factors | 1991 |
A randomised double-blind trial of cyclosporin and azathioprine in refractory rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Azathioprine; Blood Pressure; Creatinine; Cyclosporine; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Nausea; Treatment Outcome | 1991 |
167 other study(ies) available for cyclosporine and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Discovery of a Novel Potent and Selective Calcium Release-Activated Calcium Channel Inhibitor: 2,6-Difluoro-
Topics: Administration, Oral; Animals; Area Under Curve; Arthritis, Rheumatoid; Calcium; Calcium Channel Blockers; Calcium Release Activated Calcium Channels; Clinical Trials, Phase I as Topic; Drug Discovery; Humans; Jurkat Cells; Male; Mice; Mice, Inbred BALB C; Rats; Rats, Inbred Lew; Structure-Activity Relationship | 2021 |
Pure red cell aplasia secondary to rheumatoid arthritis: a case report.
Topics: Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Middle Aged; Red-Cell Aplasia, Pure; Thymoma; Thymus Neoplasms | 2021 |
Perinatal use and discontinuation of disease-modifying anti-rheumatic drugs and biologics in women with rheumatoid arthritis: a cohort study.
Topics: Abatacept; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Biological Products; British Columbia; Chloroquine; Cohort Studies; Cyclophosphamide; Cyclosporine; Deprescriptions; Female; Glucocorticoids; Gold Compounds; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Leflunomide; Logistic Models; Maternal Age; Methotrexate; Mycophenolic Acid; Odds Ratio; Preconception Care; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Rheumatology; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2020 |
Cytomegalovirus-associated supraglottic mass in a patient on immunosuppressive therapy.
Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antiviral Agents; Arthritis, Rheumatoid; Cyclosporine; Cytomegalovirus Infections; Epiglottis; Female; Ganciclovir; Humans; Immunosuppressive Agents; Laryngeal Diseases; Methylprednisolone | 2021 |
Hearing status in patients with rheumatoid arthritis.
Topics: Acoustic Impedance Tests; Adult; Arthritis, Rheumatoid; Audiometry, Pure-Tone; Azathioprine; Cochlea; Cyclosporine; Ear, Middle; Etanercept; Female; Hearing Loss, Sensorineural; Humans; Male; Middle Aged; Prospective Studies | 2017 |
Abrupt generalized pustules in patients with rheumatoid arthritis and interstitial lung disease.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; Arthritis, Rheumatoid; Biopsy; Chromones; Cyclosporine; Diagnosis, Differential; Exanthema; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Paeonia; Plant Extracts; Prednisone; Psoriasis; Skin; Sulfonamides | 2018 |
Iguratimod is effective in refractory rheumatoid arthritis patients with inadequate response to methotrexate-cyclosporin A-hydroxychloroquine-prednisone.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Chromones; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Sulfonamides; Treatment Outcome | 2018 |
Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and validation
Topics: Adalimumab; Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Chitinase-3-Like Protein 1; Cyclosporine; Disease Progression; Female; Forefoot, Human; Hand Joints; Humans; Interleukin-6; Male; Methotrexate; Middle Aged; Prognosis; Radiography; Randomized Controlled Trials as Topic; Remission Induction; Severity of Illness Index; Vascular Endothelial Growth Factor A | 2018 |
TNF-α inhibitor-induced psoriasis: A decade of experience at the Cleveland Clinic.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Child; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence; Retrospective Studies; Risk Factors; Sex Factors; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2020 |
Relapsing Course of Sulfasalazine-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Complicated by Alopecia Universalis and Vitiligo.
Topics: Alopecia; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Cyclosporine; Dermatologic Agents; Drug Hypersensitivity Syndrome; Humans; Male; Middle Aged; Prednisolone; Skin; Sulfasalazine; Symptom Flare Up; Treatment Outcome; Vitiligo | 2018 |
A physiologically based pharmacokinetic modeling approach to predict disease-drug interactions: suppression of CYP3A by IL-6.
Topics: Anticholesteremic Agents; Area Under Curve; Arthritis, Rheumatoid; Bone Marrow Transplantation; Computer Simulation; Cyclosporine; Cytochrome P-450 CYP3A; Drug Interactions; Humans; Immunosuppressive Agents; Interleukin-6; Models, Biological; Simvastatin | 2013 |
Synthesis and evaluation of cyclosporine A-loaded polysialic acid-polycaprolactone micelles for rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cell Line; Cyclosporine; Drug Carriers; Drug Delivery Systems; Fibroblasts; Micelles; Particle Size; Polyesters; Polymers; Sialic Acids | 2014 |
Cost-effectiveness of treatment strategies using combination disease-modifying anti-rheumatic drugs and glucocorticoids in early rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cost-Benefit Analysis; Cyclosporine; Drug Costs; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Prednisolone; Quality-Adjusted Life Years; Treatment Outcome | 2014 |
Clinical and serological predictors of remission in rheumatoid arthritis are dependent on treatment regimen.
Topics: Adult; Age Factors; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Prednisolone; Remission Induction; Rheumatoid Factor; Sex Factors; Treatment Outcome | 2014 |
The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study.
Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Asian People; Cohort Studies; Cyclosporine; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Incidence; Insurance; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasms; Outcome Assessment, Health Care; Proportional Hazards Models; Receptors, Tumor Necrosis Factor; Risk Factors; Taiwan; Tumor Necrosis Factor-alpha | 2014 |
Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study.
Topics: Adalimumab; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Hepatitis C, Chronic; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Methotrexate, Cyclosporine A, and Biologics Protect against Atherosclerosis in Rheumatoid Arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Atherosclerosis; Biological Products; Carotid Intima-Media Thickness; Case-Control Studies; Cyclosporine; Disease Progression; Female; Humans; Male; Methotrexate; Middle Aged; Prevalence; Severity of Illness Index | 2015 |
Therapeutic drug monitoring of cyclosporine and area under the curve prediction using a single time point strategy: appraisal using peak concentration data.
Topics: Adult; Algorithms; Antirheumatic Agents; Arthritis, Rheumatoid; Bone Marrow Transplantation; Child; Clinical Studies as Topic; Combined Modality Therapy; Crohn Disease; Cyclosporine; Drug Interactions; Drug Monitoring; Female; Graft Rejection; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Linear Models; Male; Models, Biological | 2015 |
1,25(OH)2D3 Promotes the Efficacy of CD28 Costimulation Blockade by Abatacept.
Topics: Abatacept; Animals; Apoptosis; Arthritis, Rheumatoid; Calcitriol; CD28 Antigens; Cell Line; Cell Proliferation; CHO Cells; Cricetulus; Cyclosporine; Immunosuppressive Agents; Inflammation; Lymphocyte Activation; Receptors, Antigen, T-Cell; T-Lymphocytes | 2015 |
Thrombocytopenia and Anemia with Anti-c-Mpl antibodies Effectively Treated with Cyclosporine in a Patient with Rheumatoid Arthritis and Chronic Renal Failure.
Topics: Arthritis, Rheumatoid; Bone Marrow; Cyclosporine; Erythroblasts; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Isoantibodies; Kidney Failure, Chronic; Megakaryocytes; Middle Aged; Receptors, Thrombopoietin; Red-Cell Aplasia, Pure; Renal Dialysis; Thrombocytopenia | 2016 |
Pyoderma gangrenosum: clinical characteristics, associated diseases, and responses to treatment in a retrospective cohort study of 31 patients.
Topics: Adalimumab; Adult; Age Factors; Aged; Arthritis, Rheumatoid; Cyclosporine; Dermatologic Agents; Etanercept; Female; Glucocorticoids; Hematologic Neoplasms; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Middle Aged; Prednisone; Pyoderma Gangrenosum; Retrospective Studies; Sex Factors; Survival Rate | 2017 |
Persistent clinical response of infliximab therapy in patients with refractory rheumatoid arthritis, over a 3-year period.
Topics: Antibodies, Monoclonal; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Infliximab; Magnetic Resonance Imaging; Methotrexate; Tumor Necrosis Factor-alpha | 2006 |
Generalized pustulosis induced by adalimumab in a patient with rheumatoid arthritis - a therapeutic challenge.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Cyclosporine; Drug Eruptions; Drug Therapy, Combination; Epidermis; Female; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Prednisolone | 2008 |
A case of Poncet's disease (tuberculous rheumatism).
Topics: Adult; Antitubercular Agents; Arthritis, Reactive; Arthritis, Rheumatoid; Asian People; Cyclosporine; Diagnosis, Differential; Erythema Nodosum; Female; Follow-Up Studies; Humans; Prednisolone; Radiography; Time Factors; Treatment Outcome; Tuberculosis, Osteoarticular | 2009 |
Dendriform filamentary keratopathy.
Topics: Acute Disease; Arthritis, Rheumatoid; Cornea; Corneal Diseases; Cyclosporine; Diagnosis, Differential; Drug Administration Schedule; Epithelium, Corneal; Humans; Male; Middle Aged; Prednisolone; Severity of Illness Index | 2009 |
Occult thyroid eye disease in patients presenting with dry eye symptoms.
Topics: Adult; Aged; Arthritis, Rheumatoid; Cyclosporine; Diagnosis, Differential; Dry Eye Syndromes; Female; Fluorophotometry; Graves Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Oculomotor Muscles; Retrospective Studies; Tears; Treatment Outcome | 2009 |
Psoriasiform eruption associated with alopecia areata during infliximab therapy.
Topics: Aged; Alopecia Areata; Anti-Inflammatory Agents; Antibodies, Monoclonal; Arthritis, Rheumatoid; Cyclosporine; Drug Eruptions; Female; Humans; Infliximab; Psoriasis | 2009 |
A patient with Pfeifer-Weber-Christian disease--successful therapy with cyclosporin A: case report.
Topics: Arm; Arthritis, Rheumatoid; Biopsy; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Middle Aged; Panniculitis, Nodular Nonsuppurative; Steroids; Subcutaneous Tissue; Treatment Outcome | 2010 |
Mycophenolate mofetil in the treatment of adults with advanced rheumatoid arthritis: three 24-week, randomized, double-blind, placebo- or ciclosporin-controlled trials.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Early Termination of Clinical Trials; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Multicenter Studies as Topic; Mycophenolic Acid; Placebo Effect; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome | 2010 |
How I treat LGL leukemia.
Topics: Anemia; Arthritis, Rheumatoid; Cyclosporine; Humans; Immunosuppressive Agents; Leukemia, Large Granular Lymphocytic; Methotrexate; Neutropenia | 2011 |
[Adverse effects of cyclosporin a observed in rheumatoid arthritis and psoriatic arthritis].
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Creatinine; Cyclosporine; Diarrhea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Feeding and Eating Disorders; Female; Follow-Up Studies; Hirsutism; Humans; Hypertension; Male; Methotrexate; Middle Aged; Peripheral Nervous System Diseases; Tremor | 2010 |
Treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis: a report of 2 cases.
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Alefacept; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Crohn Disease; Cyclosporine; Etanercept; Female; Humans; Immunoglobulin G; Methotrexate; Middle Aged; Mycophenolic Acid; Psoriasis; PUVA Therapy; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Treatment Outcome; Ustekinumab | 2011 |
Modern treatment strategies in rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Betamethasone; Cohort Studies; Cyclosporine; Etanercept; Female; Humans; Immunoglobulin G; Injections, Intra-Articular; Male; Methotrexate; Middle Aged; Prognosis; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Remission Induction; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
Combination of nifedipine and subtherapeutic dose of cyclosporin additively suppresses mononuclear cells activation of patients with rheumatoid arthritis and normal individuals via Ca(2+) -calcineurin-nuclear factor of activated T cells pathway.
Topics: Adult; Aged; Apoptosis; Arthritis, Rheumatoid; Calcineurin; Calcineurin Inhibitors; Calcium; Calcium Channel Blockers; Cyclosporine; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferon-gamma; Interleukin-10; Interleukin-2; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; NFATC Transcription Factors; Nifedipine; Real-Time Polymerase Chain Reaction; Signal Transduction; T-Lymphocytes | 2012 |
Hemorrhagic-acquired factor XIII deficiency associated with tocilizumab for treatment of rheumatoid arthritis.
Topics: Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid; Arthroplasty, Replacement, Hip; Cyclosporine; Down-Regulation; Factor XIII; Factor XIII Deficiency; Fibrinogen; Hematoma; Humans; Immunosuppressive Agents; Interleukin-6; Male; Methotrexate; Methylprednisolone; Middle Aged; Postoperative Complications; Sjogren's Syndrome | 2012 |
[Tubulointerstitial nephritis and uveitis (TINU syndrome) - comorbidity and complications in four patients].
Topics: Adolescent; Arthritis, Rheumatoid; Autoimmune Diseases; Child; Cyclosporine; Female; Follow-Up Studies; Humans; Male; Methotrexate; Mycophenolic Acid; Nephritis, Interstitial; Patient Care Team; Syndrome; Thyroiditis, Autoimmune; Treatment Outcome; Uveitis | 2002 |
Remission of lymphoma after drug withdrawal in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Buttocks; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Muscle Neoplasms; Muscle, Skeletal; Remission, Spontaneous | 2002 |
The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.
Topics: Acute Disease; Aged; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chronic Disease; Clinical Protocols; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Organogold Compounds; Penicillamine; Sulfasalazine; Treatment Outcome | 2002 |
[Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Placebos; Prednisolone; Randomized Controlled Trials as Topic; Sulfasalazine; Time Factors | 2003 |
Cutaneous infection due to Scedosporium apiospermum in an immunosuppressed patient.
Topics: Antifungal Agents; Arthritis, Rheumatoid; Cyclosporine; Diabetes Mellitus; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Itraconazole; Middle Aged; Mycetoma; Scedosporium; Time Factors | 2003 |
Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone.
Topics: Administration, Oral; Adult; Aged; Arthritis, Rheumatoid; Cyclosporine; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged | 2003 |
Cytomegalovirus infection in a patient with rheumatoid arthritis.
Topics: Anemia, Aplastic; Antiviral Agents; Arthritis, Rheumatoid; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Immunocompromised Host; Immunosuppressive Agents; Methotrexate; Middle Aged; Pneumonia, Viral; RNA, Viral; Treatment Outcome | 2003 |
[Idiopathic hypereosinophilic syndrome associated with rheumatoid arthritis. A case report].
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Cyclosporine; Female; Glucocorticoids; Humans; Hypereosinophilic Syndrome; Immunosuppressive Agents; Methotrexate; Middle Aged; Sulfasalazine | 2003 |
Cyclosporin A in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Synergism; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate | 2003 |
Cyclosporin and methotrexate therapy.
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Sulfasalazine | 2003 |
[Rheumatoid arthritis, pure red cell aplasia and large granular lymphocyte leukemia].
Topics: Arthritis, Rheumatoid; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents; Leukemia, Lymphoid; Male; Middle Aged; Red-Cell Aplasia, Pure; Treatment Outcome | 2003 |
Ten-year radiographic outcome in patients with rheumatoid factor positive rheumatoid arthritis treated with aggressive immunosuppressive combination therapy.
Topics: Administration, Oral; Adolescent; Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclophosphamide; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Methotrexate; Methylprednisolone; Middle Aged; Mycophenolic Acid; Prospective Studies; Pulse Therapy, Drug; Radiography; Remission Induction; Rheumatoid Factor; Treatment Outcome | 2004 |
Antiphospholipid and antisynthetase syndrome in a patient with polymyositis-rheumatoid arthritis overlap.
Topics: Adult; Antibodies, Antinuclear; Antiphospholipid Syndrome; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Hand; Humans; Ligases; Lung; Lung Diseases, Interstitial; Magnetic Resonance Imaging; Polymyositis; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Long-term relief for RA? Potential therapy targets cells that, in rheumatoid arthritis, short circuit and attack the body.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; B-Lymphocytes; Combined Modality Therapy; Cyclosporine; Humans; Methotrexate; Rituximab | 2004 |
Reversing myocardial microvascular disease in a patient with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cardiovascular Diseases; Coronary Angiography; Coronary Circulation; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Microcirculation; Middle Aged; Prednisolone; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2005 |
[When to begin rheumatism treatment? Initial combination therapy helps fastest].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Hydroxychloroquine; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Prednisolone; Randomized Controlled Trials as Topic; Sulfasalazine; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2004 |
[Three joints swollen, blood sedimentation increased. Methotrexate to be given immediately?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2004 |
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Contraindications; Cyclosporine; Disease Progression; Disease Susceptibility; DNA, Neoplasm; Etanercept; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Gene Rearrangement, B-Lymphocyte, Light Chain; Genes, Immunoglobulin; Humans; Immunocompromised Host; Immunoglobulin G; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate; Neoplasm Proteins; Receptors, Tumor Necrosis Factor; Rituximab; Tumor Necrosis Factor-alpha | 2006 |
Increased expression of CD154 (CD40L) on stimulated T-cells from patients with psoriatic arthritis.
Topics: Adult; Aged; Arthritis, Psoriatic; Arthritis, Rheumatoid; CD40 Ligand; CD8-Positive T-Lymphocytes; Cells, Cultured; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lymphocyte Activation; Male; Middle Aged; T-Lymphocytes | 2007 |
Calcineurin is expressed and plays a critical role in inflammatory arthritis.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Calcineurin; Cells, Cultured; Cyclosporine; Humans; Male; Mice; Mice, Inbred DBA; Osteoarthritis; Synovial Membrane | 2006 |
Combination therapy with cyclosporine A and anti-TNF-alpha agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Hepatitis C, Chronic; Humans; Immunoglobulin G; Immunosuppressive Agents; Liver Function Tests; Male; Middle Aged; Receptors, Tumor Necrosis Factor; Treatment Outcome; Tumor Necrosis Factor-alpha | 2007 |
Cyclosporine A inhibits IL-15-induced IL-17 production in CD4+ T cells via down-regulation of PI3K/Akt and NF-kappaB.
Topics: Adult; Aged; Arthritis, Rheumatoid; CD4-Positive T-Lymphocytes; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Down-Regulation; Female; Humans; Immunosuppressive Agents; Interleukin-15; Interleukin-17; Male; Middle Aged; Models, Immunological; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Messenger | 2007 |
Amelioration of collagen-induced arthritis in mice by a novel phosphodiesterase 7 and 4 dual inhibitor, YM-393059.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Antibody Formation; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 7; Cyclosporine; Dose-Response Relationship, Drug; Fumarates; Graft Survival; Heart Transplantation; Immunoglobulin G; Immunosuppressive Agents; Indoles; Interleukin-1beta; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Phosphodiesterase Inhibitors; Rats; Rats, Inbred Lew; Sulfonamides; Time Factors; Transplantation, Homologous | 2007 |
Prolactin and autoimmune diseases in humans.
Topics: Aminoquinolines; Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Bromocriptine; Cabergoline; Cyclosporine; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Hyperprolactinemia; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Mice; Mice, Knockout; Penicillamine; Prednisone; Prolactin; Rats; Receptors, Prolactin | 2007 |
[Cyclosporine combined with another basic drug for the management of rheumatoid arthritis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2006 |
Cyclosporin A inhibits the production of IL-17 by memory Th17 cells from healthy individuals and patients with rheumatoid arthritis.
Topics: Adult; Aged; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Arthritis, Rheumatoid; Cells, Cultured; Cyclosporine; Down-Regulation; Female; Gene Expression Regulation; Humans; Immunologic Memory; Immunosuppressive Agents; Interferon-gamma; Interleukin-17; Interleukin-2 Receptor alpha Subunit; Lectins, C-Type; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; RNA, Messenger; T-Lymphocyte Subsets; T-Lymphocytes, Helper-Inducer; Time Factors | 2008 |
[Severe pyoderma associated with rheumatoid arthritis].
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Middle Aged; Prednisolone; Pyoderma Gangrenosum; Time Factors; Treatment Outcome | 2008 |
Cyclosporine and methotrexate for severe rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Methotrexate | 1995 |
Cyclosporine and methotrexate for severe rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Methotrexate | 1995 |
Cyclosporine and methotrexate for severe rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Methotrexate | 1995 |
Cyclosporine and methotrexate for severe rheumatoid arthritis.
Topics: Anti-Bacterial Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate | 1995 |
Cyclosporine and methotrexate for severe rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lymphoma; Methotrexate | 1995 |
Cyclosporine and methotrexate for severe rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate | 1995 |
Hypertension in cyclosporin A-treated patients is independent of circulating endothelin levels.
Topics: Adult; Aldosterone; Arthritis, Rheumatoid; Atrial Natriuretic Factor; Blood Pressure; Cyclosporine; Endothelins; Female; Humans; Hypertension; Male; Middle Aged; Psoriasis; Renin; Vasopressins | 1995 |
Hematopoietic growth factors in rheumatoid arthritis: a critical approach to their use in view of possible adverse effects.
Topics: Adult; Arthritis, Rheumatoid; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leucovorin; Leukemia, Myeloid, Acute; Methotrexate; Neutropenia; Prednisolone | 1993 |
Acute myelogenous leukemia in a rheumatoid arthritis patient under cyclosporine A therapy.
Topics: Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged | 1994 |
Effect of cyclosporin A on interleukin-6 and soluble interleukin-2 receptor in patients with rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Cyclosporine; Female; Hemoglobins; Humans; Interleukin-6; Male; Middle Aged; Platelet Count; Prospective Studies; Receptors, Interleukin-2 | 1995 |
Cyclosporin A in the treatment of rheumatoid associated pyoderma gangrenosum.
Topics: Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Middle Aged; Pyoderma Gangrenosum | 1995 |
Epstein-Barr virus-associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A.
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Herpesviridae Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Male; Methotrexate; Middle Aged; Tumor Virus Infections | 1995 |
New perspectives on treating rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Drug Therapy, Combination; Humans; Methotrexate; Prednisolone | 1995 |
Rheumatoid nodules and cyclosporin A treatment.
Topics: Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Methylprednisolone; Middle Aged; Rheumatoid Nodule; Ultrasonography | 1994 |
The viable motheaten (mev) mouse--a new model for arthritis.
Topics: Animals; Arthritis, Rheumatoid; Cyclosporine; Dexamethasone; Disease Models, Animal; Foot; Ketotifen; Lung; Mice; Mice, Mutant Strains; Phenylbutazone; Polyenes; Radiation Chimera; Sirolimus; Spleen; T-Lymphocytes | 1994 |
[Bone marrow aplasia and gold salts. Review of the literature apropos of 2 cases].
Topics: Anemia, Aplastic; Antilymphocyte Serum; Arthritis, Rheumatoid; Cyclosporine; Female; Gold Sodium Thiomalate; Humans; Male; Methylprednisolone; Middle Aged; Prednisone | 1994 |
Cyclosporine, azathioprine and local therapy for pyoderma gangrenosum.
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Injections, Intralesional; Middle Aged; Pyoderma Gangrenosum; Severity of Illness Index; Triamcinolone Acetonide; Wound Healing | 1994 |
Pyoderma gangrenosum in a patient with rheumatoid arthritis responding to treatment with cyclosporin A.
Topics: Arthritis, Rheumatoid; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Pyoderma Gangrenosum | 1994 |
[Treatment of refractory rheumatoid arthritis with cyclosporine].
Topics: Administration, Oral; Adult; Aged; Arthritis, Rheumatoid; Cyclosporine; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Prospective Studies | 1994 |
Morphological and functional renal effects of long-term low-dose cyclosporin A treatment in patients with rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Atrophy; Biopsy; Cyclosporine; Female; Fibrosis; Glomerular Filtration Rate; Humans; Individuality; Kidney; Kidney Tubules; Male; Middle Aged; Time Factors | 1994 |
Circulating erythropoietin levels in pathophysiological conditions.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Arthritis, Rheumatoid; Biomarkers; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Erythropoietin; Hematocrit; Humans; Middle Aged | 1994 |
Effect of cyclosporin on the activity of cytidine deaminase and adenosine deaminase in the serum and polymorphonuclear leukocytes of patients with rheumatoid arthritis.
Topics: Adenosine Deaminase; Adult; Arthritis, Rheumatoid; Cyclosporine; Cytidine Deaminase; Female; Humans; Lymphocytes; Male; Middle Aged; Monocytes; Neutrophils | 1993 |
Renal biopsy specimens from patients with rheumatoid arthritis and apparently normal renal function after therapy with cyclosporine. Canadian Multicentre Rheumatology Group.
Topics: Adult; Aged; Arthritis, Rheumatoid; Biopsy; Cyclosporine; Female; Humans; Kidney; Kidney Diseases; Male; Middle Aged | 1994 |
The anti-arthritic and immunosuppressive effects of cyclosporin A on collagen-induced arthritis in the rhesus monkey.
Topics: Animals; Antibody Formation; Arthritis, Rheumatoid; Blood Cell Count; Blood Chemical Analysis; Collagen; Cyclosporine; Disease Models, Animal; Macaca mulatta; Male | 1993 |
Malignancies in rheumatoid arthritis patients treated with cyclosporin A.
Topics: Aged; Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Immunosuppression Therapy; Incidence; Leukemia; Lymphoproliferative Disorders; Male; Middle Aged; Risk Factors | 1993 |
Renal morphology after cyclosporin A therapy in rheumatoid arthritis patients. International Kidney Biopsy Registry of Cyclosporin (Sandimmun) in Autoimmune Diseases.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Autoimmune Diseases; Biopsy; Child; Creatinine; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Kidney; Male; Middle Aged; Registries; Statistics as Topic | 1993 |
Monitoring cyclosporin treatment.
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Monitoring; Humans | 1993 |
Cyclosporin treatment in rheumatoid arthritis is associated with an increased serum activity of beta-glucuronidase.
Topics: Arthritis, Rheumatoid; Cyclosporine; Female; Glucuronidase; Humans; Male; Middle Aged | 1993 |
Cyclosporine dosing for RA.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Interactions; Humans | 1995 |
Comparison of the dapsone recovery ratio and the erythromycin breath test as in vivo probes of CYP3A activity in patients with rheumatoid arthritis receiving cyclosporine.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Breath Tests; Carbon Radioisotopes; Cyclosporine; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Dapsone; Erythromycin; Female; Humans; Male; Middle Aged; Mixed Function Oxygenases; Predictive Value of Tests; Protein Synthesis Inhibitors | 1996 |
The clinical and immunological effects of cyclosporin A on patients with rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; C-Reactive Protein; Creatinine; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interleukin-2; Male; Middle Aged; Receptors, Interleukin-2; T-Lymphocytes | 1995 |
Treatment of progressive rheumatoid interstitial lung disease with cyclosporine.
Topics: Arthritis, Rheumatoid; Cyclosporine; Humans; Immunosuppressive Agents; Lung; Male; Middle Aged; Pulmonary Fibrosis; Radiography, Thoracic; Tomography, X-Ray Computed | 1995 |
[Cyclosporin A in the treatment of refractory rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged | 1995 |
Renal biopsy findings and followup of renal function in rheumatoid arthritis patients treated with cyclosporin A. An update from the International Kidney Biopsy Registry.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Creatinine; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Risk Factors | 1996 |
Chronic cyclosporine nephrotoxicity in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Humans; Kidney Diseases; Organ Transplantation | 1996 |
Longterm low dose cyclosporine in patients with rheumatoid arthritis: renal function loss without structural nephropathy.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Cyclosporine; Female; Humans; Kidney; Kidney Diseases; Male; Middle Aged | 1996 |
[Successful treatment of interstitial pneumonitis with cyclosporin A in a patient with rheumatoid arthritis accompanied by acute interstitial nephritis].
Topics: Acute Disease; Arthritis, Rheumatoid; Cell Adhesion Molecules; Cyclosporine; Endothelium; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Nephritis, Interstitial | 1996 |
Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporin A therapy.
Topics: Acute-Phase Proteins; Arthritis, Rheumatoid; Bone Density; C-Reactive Protein; Cyclosporine; Dehydroepiandrosterone Sulfate; Drug Resistance; Female; Humans; Insulin-Like Growth Factor I; Joints; Male; Methotrexate; Middle Aged; Osteocalcin; Retreatment | 1996 |
The benefit/risk ratio of low dose cyclosporin A in rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Cost-Benefit Analysis; Cyclosporine; Humans; Middle Aged | 1996 |
Successful treatment with cyclosporin A of pure red cell aplasia associated with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cyclosporine; Female; Follow-Up Studies; Hemoglobins; Humans; Middle Aged; Red-Cell Aplasia, Pure; Reticulocyte Count | 1996 |
Treatment of cyclosporine-induced gingival hypertrophy.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Female; Gingival Hypertrophy; Humans; Metronidazole | 1997 |
Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A or methotrexate: comment on the article by Pasero et al.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Humans; Joint Diseases; Methotrexate | 1997 |
Central nervous system toxicity of cyclosporin A treatment in rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Blood-Brain Barrier; Central Nervous System Diseases; Cyclosporine; Eye Movements; Female; Humans | 1997 |
Testosterone metabolism and cyclosporin A treatment in rheumatoid arthritis.
Topics: Adult; Androgens; Arthritis, Rheumatoid; Cells, Cultured; Cyclosporine; Female; Follow-Up Studies; Humans; Macrophages; Male; Middle Aged; Synovial Fluid; Testosterone | 1997 |
[Rheumatoid arthritis. Begin early aggressive therapy].
Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate | 1997 |
Cyclosporin can be used in early rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Humans | 1997 |
[The effect of cyclosporin A (Sandimmun) on the level of soluble interleukin-2 receptors in rheumatoid arthritis].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Interleukin-2; Male; Solubility; Time Factors | 1997 |
A case report of a patient who has pure red cell aplasia and rheumatoid arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Red-Cell Aplasia, Pure | 1997 |
[Therapy of refractory rheumatoid arthritis. Cyclosporin and methotrexate combination].
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Data Interpretation, Statistical; Drug Therapy, Combination; Humans; Magnetic Resonance Imaging; Methotrexate; Methylprednisolone; Time Factors | 1998 |
Cyclosporin A and FK-506 inhibit development of superantigen-potentiated collagen-induced arthritis in mice.
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Collagen; Cyclosporine; Enterotoxins; Immunosuppressive Agents; Male; Mice; Mice, Inbred DBA; Receptors, Interleukin-2; Superantigens; T-Lymphocytes; Tacrolimus | 1998 |
[Rheumatoid arthritis. Conservative therapeutic possibilities today and in the future].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Forecasting; Gold; Humans; Penicillamine; Sulfasalazine | 1998 |
[Sandimmun Optoral now approved in Germany. Treatment of rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Approval; Drug Combinations; Germany; Humans; Methotrexate | 1998 |
Androgenizing effects of low-dose cyclosporin in male patients with early RA.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Dihydrotestosterone; Humans; Male; Middle Aged; Prostate-Specific Antigen; Sex Hormone-Binding Globulin | 1998 |
Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. Differential regulation of hsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytokines, s
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cells, Cultured; Cyclosporine; Cytokines; Dexamethasone; DNA-Binding Proteins; Fibroblasts; Fluorescent Antibody Technique, Direct; Heat Shock Transcription Factors; HSP70 Heat-Shock Proteins; Humans; Methotrexate; Physical Stimulation; Synovial Membrane; Transcription Factors | 1998 |
[Basic therapeutics in the management of various forms of arthritis].
Topics: Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Humans; Methotrexate; Polymyalgia Rheumatica; Remission Induction; Spondylitis; Spondylitis, Ankylosing; Sulfasalazine | 1998 |
No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Comorbidity; Cyclosporine; Female; Humans; Male; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome | 1998 |
A new target for aspirin.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Calcium-Calmodulin-Dependent Protein Kinases; Cyclooxygenase Inhibitors; Cyclosporine; Dose-Response Relationship, Drug; Enzyme Inhibitors; I-kappa B Kinase; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Prednisolone; Protein Serine-Threonine Kinases | 1998 |
Drug-combination therapy of rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Cyclophosphamide; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Fluocortolone; Glucocorticoids; Humans; Kidney; Longitudinal Studies; Male; Methotrexate; Middle Aged | 1998 |
Cyclosporine in the treatment of autoimmune disorders: a 10-year experience.
Topics: Adult; Aged; Arthritis, Rheumatoid; Autoimmune Diseases; Behcet Syndrome; Central Nervous System Diseases; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Retrospective Studies; Vasculitis | 1998 |
Peripheral ulcerative keratitis--an extracutaneous neutrophilic disorder: report of a patient with rheumatoid arthritis, pustular vasculitis, pyoderma gangrenosum, and Sweet's syndrome with an excellent response to cyclosporine therapy.
Topics: Arthritis, Rheumatoid; Corneal Ulcer; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Middle Aged; Pyoderma Gangrenosum; Sweet Syndrome; Treatment Outcome; Vasculitis | 1999 |
Validity of area-under-the-curve analysis to summarize effect in rheumatoid arthritis clinical trials.
Topics: Antirheumatic Agents; Area Under Curve; Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Evaluation Studies as Topic; Humans; Methotrexate; Prednisone; Randomized Controlled Trials as Topic; Reproducibility of Results; Rheumatology; Sulfasalazine; Treatment Outcome | 1999 |
Colitis induced by interaction of cyclosporine A and non-steroidal anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Child; Colitis; Cyclosporine; Diclofenac; Drug Interactions; Female; Humans; Immunosuppressive Agents; Indomethacin | 1999 |
Cyclosporin A therapy in rheumatoid arthritis: only strict application of the guidelines for safe use can prevent irreversible renal function loss.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Creatinine; Cyclosporine; Female; Guidelines as Topic; Humans; Male; Middle Aged; Renal Insufficiency; Treatment Outcome | 1999 |
US consensus guidelines for the use of cyclosporin A in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Resistance; Humans; Practice Guidelines as Topic; Risk Factors; United States | 1999 |
Long-term cyclosporin continuation rates in rheumatoid arthritis patients.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Male; Middle Aged; Retrospective Studies; Time | 1999 |
Combination therapy in rheumatoid arthritis: a comment.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine; Treatment Outcome | 1999 |
Treatment considerations in early rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Patient Selection; Risk; Sulfasalazine; Time Factors; Treatment Outcome | 1997 |
Combination therapy in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Synergism; Drug Therapy, Combination; Humans; Methotrexate | 1999 |
Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged | 1999 |
High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism.
Topics: Adult; Aged; Arthritis, Rheumatoid; Cell Separation; Cells, Cultured; Cyclosporine; Humans; Interleukin-15; Interleukin-17; Interleukin-2; Ionomycin; Leukocytes, Mononuclear; Methylprednisolone; Middle Aged; Osteoarthritis; Phytohemagglutinins; Synovial Fluid; Tetradecanoylphorbol Acetate | 2000 |
Epstein-Barr virus-associated Hodgkin's lymphoma and legionella pneumophila infection complicating treatment of juvenile rheumatoid arthritis with methotrexate and cyclosporine A.
Topics: Arthritis, Rheumatoid; Cyclosporine; Epstein-Barr Virus Infections; Fatal Outcome; Female; Hodgkin Disease; Humans; Immunosuppressive Agents; Infant; Legionnaires' Disease; Methotrexate | 2000 |
Cyclosporine as a treatment for multicentric reticulohistiocytosis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Child; Cyclosporine; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents | 2000 |
[Pharmacotherapy of patients with (early) rheumatoid arthritis].
Topics: Agranulocytosis; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Humans; Methotrexate; Sulfasalazine | 2000 |
Cytokine mRNA in the joints and draining lymph nodes of rats with adjuvant arthritis and effects of cyclosporin A.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Chemotaxis, Leukocyte; Cyclosporine; Cytokines; Disease Models, Animal; Gene Expression Regulation; Humans; Hypersensitivity, Delayed; Immunosuppressive Agents; Interferon-gamma; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-4; Interleukin-6; Lymph Nodes; Male; Models, Animal; Rats; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sialoglycoproteins; Synovial Membrane; Tarsus, Animal; Tumor Necrosis Factor-alpha | 2000 |
An experimental study in the chick embryo chorioallantoic membrane of the anti-angiogenic activity of cyclosporine in rheumatoid arthritis versus osteoarthritis.
Topics: Allantois; Animals; Arthritis, Rheumatoid; Chick Embryo; Chorion; Cyclosporine; Humans; Neovascularization, Pathologic; Osteoarthritis; Synovial Membrane; Time Factors | 2000 |
Cyclosporin A inhibits CD69 expression induced on synovial fluid and peripheral blood lymphocytes by interleukin 15.
Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Arthritis, Rheumatoid; Cells, Cultured; Chemokines; Cyclosporine; Cytokines; Dose-Response Relationship, Drug; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Immunosuppressive Agents; Interleukin-15; Lectins, C-Type; Lymphocyte Activation; Lymphocytes; Methotrexate; Synovial Fluid; Up-Regulation | 2000 |
Successful use of cyclosporin A for the treatment of acute interstitial pneumonitis associated with rheumatoid arthritis.
Topics: Acute Disease; Adrenal Cortex Hormones; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Middle Aged; Treatment Outcome | 2000 |
Cyclosporin for sulphasalazine-induced aplastic anaemia in a patient with early rheumatoid arthritis.
Topics: Aged; Anemia, Aplastic; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Immunosuppressive Agents; Sulfasalazine; Treatment Outcome | 2000 |
[Efficacy, tolerability and safety of cyclosporine for microemulsion in the treatment of active rheumatoid arthritis. Open study].
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Creatinine; Cyclosporine; Emulsions; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Treatment Outcome; Uric Acid | 2000 |
Topical cyclosporin stimulates neovascularization in resolving sterile rheumatoid central corneal ulcers.
Topics: Administration, Topical; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Arthritis, Rheumatoid; Corneal Ulcer; Cyclosporine; Epithelium, Corneal; Female; Humans; Male; Middle Aged; Neovascularization, Physiologic; Retrospective Studies | 2000 |
[Serum soluble CD44 isoform variant 5 level in patients with seropositive rheumatoid arthritis treated with cyclosporin A].
Topics: Adult; Aged; Arthritis, Rheumatoid; Cyclosporine; Female; Follow-Up Studies; Humans; Hyaluronan Receptors; Male; Middle Aged; Treatment Outcome | 2000 |
Tachykinin activation of human monocytes from patients with rheumatoid arthritis: in vitro and ex-vivo effects of cyclosporin A.
Topics: Arthritis, Rheumatoid; Carcinogens; Cells, Cultured; Cyclosporine; Humans; Immunosuppressive Agents; In Vitro Techniques; Monocytes; Neurokinin A; Peptide Fragments; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Receptors, Neurokinin-3; Receptors, Tachykinin; Respiratory Burst; Substance P; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2001 |
Conventional DMARD options for patients with a suboptimal response to methotrexate.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2001 |
Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, T-Cell; Male; Methotrexate; Middle Aged; Neutropenia; Prednisone; Recurrence; Red-Cell Aplasia, Pure; Remission Induction; T-Lymphocytes, Cytotoxic | 2001 |
[Regression of Epstein-Barr virus associated lymphoma after methotrexate and cyclosporine A withdrawal in a patient with rheumathoid arthritis].
Topics: Arthritis, Rheumatoid; Cyclosporine; Epstein-Barr Virus Infections; Female; Humans; Immunosuppressive Agents; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged | 2001 |
Effective treatment of early rheumatoid arthritis with a combination of methotrexate, prednisolone and cyclosporin.
Topics: Adult; Aged; Arthritis, Rheumatoid; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Prednisolone; Probability; Prognosis; Severity of Illness Index; Treatment Outcome | 2002 |
Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor a production by rheumatoid synoviocytes.
Topics: 1-Methyl-3-isobutylxanthine; Antimetabolites; Antirheumatic Agents; Arthritis, Rheumatoid; Bucladesine; Calcineurin Inhibitors; Cells, Cultured; Cyclic AMP; Cyclosporine; Cytokines; Dideoxyadenosine; Fibroblasts; Gene Expression; Humans; Immunosuppressive Agents; Interleukin-10; Interleukin-15; Phosphodiesterase Inhibitors; RNA, Messenger; Synovial Membrane; Tacrolimus; Tumor Necrosis Factor-alpha | 2002 |
Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset.
Topics: Adult; Age of Onset; Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Cohort Studies; Cyclosporine; DNA; Drug Therapy, Combination; Epitopes; Female; Gene Frequency; Histocompatibility Testing; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Immunosuppressive Agents; Joints; Male; Middle Aged; Rheumatoid Factor; Severity of Illness Index | 2002 |
["Critical dose" drugs. Aut-idem could cause problems here].
Topics: Arthritis, Rheumatoid; Biological Availability; Cyclosporine; Dose-Response Relationship, Drug; Drugs, Generic; Humans; Therapeutic Equivalency | 2002 |
Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections.
Topics: Adolescent; Adult; Aged; Antibodies, Anticardiolipin; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoid; Child; Child, Preschool; Chloroquine; Cyclosporine; Drug Combinations; Etanercept; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Staphylococcal Infections; Staphylococcus aureus | 2002 |
[Successful use of immunosuppressive agents for the treatment of progressive rheumatoid interstitial lung disease: a case report].
Topics: Arthritis, Rheumatoid; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Macrophages, Alveolar; Male; Middle Aged | 2002 |
Idiopathic hypereosinophilic syndrome in a patient with long-standing rheumatoid arthritis: a case report.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Cyclosporine; Eosinophils; Female; Humans; Hypereosinophilic Syndrome; Immunosuppressive Agents; Leukocyte Count; Middle Aged; Prednisolone | 2002 |
Successful treatment of progressive rheumatoid interstitial lung disease with cyclosporine: a case report.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclophosphamide; Cyclosporine; Disease Progression; Female; Glucocorticoids; Humans; Lung Diseases, Interstitial; Middle Aged; Prednisolone; Radiography; Treatment Outcome | 2002 |
Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cells, Cultured; Chemokine CXCL1; Chemokines, CXC; Chemotactic Factors; Cyclosporine; Fibroblasts; Growth Substances; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-17; Interleukin-8; Kinetics; MAP Kinase Signaling System; Methotrexate; NF-kappa B; Receptors, Interleukin; Receptors, Interleukin-17; Recombinant Proteins; RNA, Messenger; Signal Transduction; Synovial Membrane; Transcription, Genetic; U937 Cells | 2002 |
Cyclosporin A in Rheumatoid Arthritis: Aspects for Long-term Treatment. Proceedings of a meeting of the 24th Scandinavian Congress of Rheumatology. Malmö, Sweden, 3 June 1992.
Topics: Arthritis, Rheumatoid; Cyclosporine; Humans | 1992 |
Pneumocystis carinii pneumonia following cyclosporine A and methotrexate treated rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Methotrexate; Pneumonia, Pneumocystis | 1992 |
Interaction of cyclosporine A and nonsteroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Renal Circulation | 1992 |
Recalcitrant pyoderma gangrenosum--two cases successfully treated with cyclosporin A.
Topics: Aged; Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Middle Aged; Pyoderma | 1992 |
Cyclosporine and chloroquine synergistically inhibit the interferon-gamma production by CD4 positive and CD8 positive synovial T cell clones derived from a patient with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; CD4 Antigens; CD8 Antigens; Cells, Cultured; Chloroquine; Cyclosporine; Dose-Response Relationship, Drug; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Humans; Interferon-gamma; Synovial Membrane; T-Lymphocytes | 1992 |
Cyclosporine A for the treatment of necrotizing scleritis and corneal melting in patients with rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Cornea; Corneal Diseases; Cyclosporine; Female; Humans; Male; Middle Aged; Scleritis | 1992 |
Epstein-Barr virus-associated lymphoma in a patient with rheumatoid arthritis treated with cyclosporine.
Topics: Arthritis, Rheumatoid; Burkitt Lymphoma; Cyclosporine; Humans; Male; Middle Aged | 1992 |
Cyclosporine therapy for autoimmune disease.
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Behcet Syndrome; Cyclosporine; Diabetes Mellitus, Type 1; Humans; Kidney Diseases; Psoriasis | 1992 |
Treatment of rheumatoid corneal ulcers.
Topics: Arthritis, Rheumatoid; Corneal Ulcer; Cyclosporine; Eyelids; Humans | 1992 |
Paracentral rheumatoid corneal ulceration. Clinical features and cyclosporine therapy.
Topics: Aged; Antibodies, Monoclonal; Arthritis, Rheumatoid; Contact Lenses; Cornea; Corneal Ulcer; Cyclosporine; Female; HLA-DR Antigens; Humans; Immunoenzyme Techniques; Immunoglobulins; Keratoplasty, Penetrating; Lymphocytes; Male; Middle Aged; Recurrence; Tissue Adhesives; Visual Acuity | 1992 |
Soluble HLA-DR molecules in patients with HLA class II versus class I associated disorders.
Topics: Arthritis, Psoriatic; Arthritis, Rheumatoid; Autoimmune Diseases; beta 2-Microglobulin; Blood Sedimentation; Cyclosporine; HLA-DR Antigens; Humans; Interferon-gamma; Longitudinal Studies; Lupus Erythematosus, Systemic; Lyme Disease; Scleroderma, Localized; Spondylitis; Vasculitis | 1991 |